
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D7146689B748931C1466003089BB37.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="eurjmedres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="European Journal of Medical Research">
<meta name="citation_title" content="Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis">
<meta name="citation_author" content="Abdelmonam M Hagag">
<meta name="citation_author_institution" content="Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt">
<meta name="citation_author" content="Muhammed E Kormod">
<meta name="citation_author_institution" content="Faculty of Medicine, Al-Azhar University, Cairo, Egypt">
<meta name="citation_author" content="Mahmoud Elmwafy Ads">
<meta name="citation_author_institution" content="Faculty of Medicine, Mansoura University, Mansoura, Egypt">
<meta name="citation_author" content="Mennatullah A El-Refaay">
<meta name="citation_author_institution" content="Faculty of Medicine, October 6 University, Cairo, Egypt">
<meta name="citation_author" content="Omnia M Abozaid">
<meta name="citation_author_institution" content="Faculty of Medicine, Minia University, Minia, Egypt">
<meta name="citation_author" content="Omar A Ghanem">
<meta name="citation_author_institution" content="Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt">
<meta name="citation_author" content="Mazen Yasser">
<meta name="citation_author_institution" content="Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt">
<meta name="citation_author" content="Karim M Abdelmoaty">
<meta name="citation_author_institution" content="Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt">
<meta name="citation_author" content="Alaa Mahmoud Khedr">
<meta name="citation_author_institution" content="Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt">
<meta name="citation_author" content="Gregory W Albers">
<meta name="citation_author_institution" content="Department of Neurology, Stanford University, Palo Alto, CA USA">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="30">
<meta name="citation_firstpage" content="726">
<meta name="citation_doi" content="10.1186/s40001-025-02983-9">
<meta name="citation_pmid" content="40775658">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/pdf/40001_2025_Article_2983.pdf">
<meta name="description" content="Stroke was the second leading cause of death and the third leading cause of disability worldwide in 2019. Alteplase is an FDA-approved medication for the treatment of patients with ischemic stroke within 4.5 h. However, Tenecteplase is an ...">
<meta name="og:title" content="Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Stroke was the second leading cause of death and the third leading cause of disability worldwide in 2019. Alteplase is an FDA-approved medication for the treatment of patients with ischemic stroke within 4.5 h. However, Tenecteplase is an ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12333306">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40001-025-02983-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40001_2025_Article_2983.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333306%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12333306/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12333306/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-eurjmedres.png" alt="European Journal of Medical Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to European Journal of Medical Research" title="Link to European Journal of Medical Research" shape="default" href="https://eurjmedres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Eur J Med Res</button></div>. 2025 Aug 8;30:726. doi: <a href="https://doi.org/10.1186/s40001-025-02983-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40001-025-02983-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur%20J%20Med%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Eur%20J%20Med%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hagag%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Abdelmonam M Hagag</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Abdelmonam M Hagag</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hagag%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Abdelmonam M Hagag</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kormod%20ME%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Muhammed E Kormod</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Muhammed E Kormod</span></h3>
<div class="p">
<sup>2</sup>Faculty of Medicine, Al-Azhar University, Cairo, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kormod%20ME%22%5BAuthor%5D" class="usa-link"><span class="name western">Muhammed E Kormod</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ads%20ME%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Mahmoud Elmwafy Ads</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Mahmoud Elmwafy Ads</span></h3>
<div class="p">
<sup>3</sup>Faculty of Medicine, Mansoura University, Mansoura, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ads%20ME%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahmoud Elmwafy Ads</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Refaay%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Mennatullah A El-Refaay</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Mennatullah A El-Refaay</span></h3>
<div class="p">
<sup>4</sup>Faculty of Medicine, October 6 University, Cairo, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22El-Refaay%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Mennatullah A El-Refaay</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abozaid%20OM%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Omnia M Abozaid</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Omnia M Abozaid</span></h3>
<div class="p">
<sup>5</sup>Faculty of Medicine, Minia University, Minia, Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abozaid%20OM%22%5BAuthor%5D" class="usa-link"><span class="name western">Omnia M Abozaid</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghanem%20OA%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Omar A Ghanem</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Omar A Ghanem</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ghanem%20OA%22%5BAuthor%5D" class="usa-link"><span class="name western">Omar A Ghanem</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yasser%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Mazen Yasser</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Mazen Yasser</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yasser%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mazen Yasser</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelmoaty%20KM%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Karim M Abdelmoaty</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Karim M Abdelmoaty</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abdelmoaty%20KM%22%5BAuthor%5D" class="usa-link"><span class="name western">Karim M Abdelmoaty</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khedr%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Alaa Mahmoud Khedr</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Alaa Mahmoud Khedr</span></h3>
<div class="p">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khedr%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Alaa Mahmoud Khedr</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Albers%20GW%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Gregory W Albers</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Gregory W Albers</span></h3>
<div class="p">
<sup>6</sup>Department of Neurology, Stanford University, Palo Alto, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Albers%20GW%22%5BAuthor%5D" class="usa-link"><span class="name western">Gregory W Albers</span></a>
</div>
</div>
<sup>6</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Faculty of Medicine, Zagazig University, As Sanafin Al Qibliyyah, Minya Al Qamh, Zagazig, Sharqia Egypt </div>
<div id="Aff2">
<sup>2</sup>Faculty of Medicine, Al-Azhar University, Cairo, Egypt </div>
<div id="Aff3">
<sup>3</sup>Faculty of Medicine, Mansoura University, Mansoura, Egypt </div>
<div id="Aff4">
<sup>4</sup>Faculty of Medicine, October 6 University, Cairo, Egypt </div>
<div id="Aff5">
<sup>5</sup>Faculty of Medicine, Minia University, Minia, Egypt </div>
<div id="Aff6">
<sup>6</sup>Department of Neurology, Stanford University, Palo Alto, CA USA </div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Handling editor: Carlo Colosimo</p></div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 11; Accepted 2025 Jul 26; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12333306  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40775658/" class="usa-link">40775658</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Stroke was the second leading cause of death and the third leading cause of disability worldwide in 2019. Alteplase is an FDA-approved medication for the treatment of patients with ischemic stroke within 4.5 h. However, Tenecteplase is an alternative. We aimed to assess the safety, efficacy, and the best dose of tenecteplase vs alteplase.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methodology</h3>
<p id="Par2">We followed the PRISMA 2020 guidelines. We searched PubMed, Scopus, Web of Science, and the Cochrane Library until November 2024. We included RCTs that compared tenecteplase with alteplase in acute ischemic stroke patients within 4.5 h of onset. Relative risk, 95% CI, and random effects models were used. Our primary endpoints were excellent functional outcomes and mortality. An excellent functional outcome was defined as a modified Rankin Score of 0–1 at 90 days. The Risk of Bias 2 tool from Cochrane was used to assess the quality of the studies.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Thirteen RCTs met our inclusion criteria, including 9053 patients, 4416 of whom had tenecteplase. Six studies showed a low risk of bias, and the other 7 had some concerns either in their randomization process or in the deviation from the intended intervention. Tenecteplase 0.25 mg/kg had a significantly better performance in achieving excellent functional outcomes (p value 0.008), but no difference was observed in mortality rates (P value 0.37). On the other hand, no difference was observed in comparing either TNK 0.1 mg/kg or TNK 0.4 mg/kg versus alteplase in the reported outcomes. A meta-regression revealed that a reduction in the baseline NIHSS score had a significant effect on favorable functional outcomes (P value 0.025). Sensitivity analysis for outcomes comparing either TNK 0.25 mg/kg and TNK 0.1 mg/kg versus alteplase showed that no single study removal affected the significance of the study, while Kvistad 2022 and Logallo 2017 removal changed the significance of outcomes comparing TNK 0.4 mg/kg versus alteplase.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">When compared with alteplase, 0.25 mg/kg tenecteplase is superior for achieving excellent functional outcomes and is not inferior in terms of major neurological improvement or death rates. TNKs at 0.25 mg/kg appear to be the optimal dose and a desirable alternative to alteplase.</p></section><section id="sec5"><h3 class="pmc_sec_title">PROSPERO Registration Number</h3>
<p id="Par5">CRD42024596896</p></section><section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s40001-025-02983-9.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Tenecteplase, Alteplase, Acute ischemic stroke, TNK, RtPA</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par16">Stroke is a significant global health burden, being the second-leading cause of death and the third-leading cause of disability worldwide in 2019 [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Ischemic stroke (IS) is caused by vessel occlusion, leading to diminished blood flow to the brain tissue, resulting in neurological impairment, and is the most common subtype [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Rapid reperfusion via intravenous fibrinolytics with or without mechanical thrombectomy is the main therapeutic goal [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>].</p>
<p id="Par17">Alteplase (tPA) is a tissue plasminogen activator that is used for rapid reperfusion. It is the only fibrinolytic agent that is FDA-approved for managing patients with acute ischemic stroke, and its approval is limited to treatment within 3 h of stroke onset [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. However, the benefit was extended to 4.5 h on the basis of the European Cooperative Acute Stroke Study (ECASS) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. As a result, the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organization (ESO) recommend alteplase as the first-line therapy for AIS for up to 4.5 h [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>] On the other hand, alteplase has several limitations, including a short half-life requiring a bolus dose followed by a 1 h infusion, hemorrhagic complications, and recanalization rates below 40% [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Therefore, exploring alternative therapies is essential.</p>
<p id="Par18">When compared with alteplase, tenecteplase (TNK) is a third-generation tissue plasminogen activator that is genetically modified with 15-fold greater fibrin specificity and 80-fold greater resistance to plasminogen activator inhibitor-1 [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>] which makes it a promising alternative. The FDA first approved TNK for managing patients with ST-segment elevation myocardial infarction (STEMI) before percutaneous coronary intervention (PCI) became the gold standard of management. When compared alteplase, TNK has a longer half-life and lower plasma clearance, allowing its administration as a bolus dose [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Several randomized controlled trials (RCTs) have assessed the safety and efficacy of tenecteplase versus alteplase with various TNK doses (0.1, 0.25, and 0.4 mg/kg) for patients with acute ischemic stroke [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Some national guidelines recommend the use of tenecteplase in ischemic stroke management [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>], and the last European Stroke Organization (ESO) guidelines recommend TNK at a dose of 0.25 mg/kg/kg as an alternative to alteplase [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Recent RCTs, such as Parsons 2024, Meng 2024, and Muir 2024 [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], have provided additional data. This study aimed to evaluate the safety and efficacy of tenecteplase compared with those of alteplase, discuss its limitations, and clarify the optimal dose of tenecteplase. We further aimed to assess the effect of the baseline NIH stroke scale (NIHSS) score, mean age, sex, and hypertension on the efficacy of tenecteplase.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methodology</h2>
<p id="Par19">This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Review and Meta-Analysis 2020 (PRISMA) guidelines [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. The prespecified protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO) under the number: CRD42024596896.</p>
<p id="Par20">We included studies that included the following: (1) patients with acute ischemic stroke within 4.5 h of onset and eligible for thrombolytics (population), (2) those that compared tenecteplase (intervention) with alteplase (comparison), (3) those reporting their safety and efficacy outcomes, including excellent functional outcomes and mortality rates, (outcomes). (4) studies should be randomized control trials (study design), 5/written in the English language, and 6/working with only human patients. We excluded studies that did not meet these criteria, and conference abstract articles, protocols, animal studies, and observational studies.</p>
<section id="Sec3"><h3 class="pmc_sec_title">Search strategy</h3>
<p id="Par21">We systematically searched four key databases: PubMed, Web of Science, Scopus, and the Cochrane Library, up to 17th November 2024. We conducted a comprehensive search of titles and abstracts via specific keywords: (Tenecteplase OR TNK) AND (Alteplase) AND (Acute ischemic stroke). We used the same search strategy for the four databases, which is provided in File 1 supplementary material.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Screening and data extraction</h3>
<p id="Par22">After the papers were collected, they were uploaded to EndNote X9 to automatically remove duplicates. The results were then reuploaded to Rayyan for title and abstract screening. Two reviewers (OA and MY) independently screened the papers to identify those suspected of being eligible. Any conflicts were resolved through negotiation with the first author (AM). Four independent reviewers (OA, KM, MA, and ME) then assessed the full articles, dividing the workload among the reviewers. OA and KM independently reviewed half of the articles, whereas MA and ME reviewed the other half. Any conflicts were resolved by revisiting the eligibility criteria and negotiating with the first author (AM).</p>
<p id="Par23">Four reviewers independently extracted the data, which included the type of study, methods of randomization and blinding, site and ethical approval committee, inclusion criteria for each paper, main results, total sample size, and number of patients in each group. The following additional data were also collected: age, sex, baseline NIHSS score, mRS score, onset-to-needle time, door-to-needle time, risk factors, and study outcomes.</p>
<p id="Par24">The primary efficacy outcomes were major neurological improvement and excellent functional outcomes. Excellent functional outcomes were defined as mRS scores of 0–1 at 90 days. Major neurological improvement was defined according to the RCT articles. Most studies defined major neurological improvement as a reduction in the NIHSS score of ≥ 8 points at 24 h. Some studies defined it as a reduction of ≥ 4 in some papers, or an NIHSS score of 0 or 1 at 24 h. We summarized the definitions in Table <a href="#Tab1" class="usa-link">1</a>. We performed a subgroup analysis to compare studies that used ≥ 8 points at 24 h as a definition and studies that used ≥ 4 points at 24 h to compare the outcome results between the two definitions.
</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Summary of the included studies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Study ID</th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="2" rowspan="1">Tenecteplase group</th>
<th align="left" colspan="1" rowspan="1">Alteplase group</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Study design</th>
<th align="left" colspan="1" rowspan="1">Major neurological improvement definition</th>
<th align="left" colspan="1" rowspan="1">Total sample size</th>
<th align="left" colspan="1" rowspan="1">Patients N</th>
<th align="left" colspan="1" rowspan="1">Dose</th>
<th align="left" colspan="1" rowspan="1">Patients N</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Haley [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]</td>
<td align="left" colspan="1" rowspan="1">Small, multicenter, randomized, double-blind, controlled clinical trial</td>
<td align="left" colspan="1" rowspan="1">A ≥ 8-point improvement compared with baseline, or a score of 0, on the National Institutes of Health Stroke Scale5 at 24 h</td>
<td align="left" colspan="1" rowspan="1">112</td>
<td align="left" colspan="2" rowspan="1">
<p>31 Patients (0.1 mg/kg)</p>
<p>31 Patients (0.25 mg/kg)</p>
<p>19 Patients (0.4 g/kg)</p>
</td>
<td align="left" colspan="1" rowspan="1">31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Parsons [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</td>
<td align="left" colspan="1" rowspan="1">Randomized, open-label, blinded trial</td>
<td align="left" colspan="1" rowspan="1">Defined as a reduction from baseline of 8 or more points on the NIHSS</td>
<td align="left" colspan="1" rowspan="1">75</td>
<td align="left" colspan="2" rowspan="1">
<p>25 Patients (0.1 mg/kg) maximum 10 mg</p>
<p>25 Patients (0.25 mg/kg) maximum dose 25 mg</p>
</td>
<td align="left" colspan="1" rowspan="1">25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Huang [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</td>
<td align="left" colspan="1" rowspan="1">Single-Centre, phase 2, prospective, randomized, open-label, blinded-endpoint study</td>
<td align="left" colspan="1" rowspan="1">Reduction of NIHSS score of 8 points or more or NIHSS score of zero or one at 24–48 h post-treatment</td>
<td align="left" colspan="1" rowspan="1">104</td>
<td align="left" colspan="1" rowspan="1">52</td>
<td align="left" colspan="1" rowspan="1">0.25 mg/kg (maximum 25 mg)</td>
<td align="left" colspan="1" rowspan="1">52</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]</td>
<td align="left" colspan="1" rowspan="1">Phase 3, randomized, open-label, blind endpoint, superiority trial</td>
<td align="left" colspan="1" rowspan="1">Either an NIHSS score of 0 at 24 h or a reduction in NIHSS score of at least 4 points at 24 h compared with baseline</td>
<td align="left" colspan="1" rowspan="1">1100</td>
<td align="left" colspan="1" rowspan="1">549</td>
<td align="left" colspan="1" rowspan="1">0.4 mg/kg (maximum 40 mg)</td>
<td align="left" colspan="1" rowspan="1">551</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Campbell 2018</td>
<td align="left" colspan="1" rowspan="1">Multicenter, prospective, randomized, open-label, blinded-outcome trial</td>
<td align="left" colspan="1" rowspan="1">A reduction of at least 8 points or a score of 0 or 1 on the NIHSS at 72 h, as assessed by site personnel</td>
<td align="left" colspan="1" rowspan="1">202</td>
<td align="left" colspan="1" rowspan="1">101</td>
<td align="left" colspan="1" rowspan="1">0.25 mg/kg of body weight (maximum dose: 25 mg)</td>
<td align="left" colspan="1" rowspan="1">101</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Menon [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]</td>
<td align="left" colspan="1" rowspan="1">The AcT trial was a pragmatic, multicenter, open-label, registry-linked, randomized, controlled trial</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1577</td>
<td align="left" colspan="1" rowspan="1">806</td>
<td align="left" colspan="1" rowspan="1">Tenecteplase 0.25 mg/kg (maximum 25 mg)</td>
<td align="left" colspan="1" rowspan="1">771</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Li [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]</td>
<td align="left" colspan="1" rowspan="1">A multicenter, prospective, randomized, open-label, blinded endpoint, phase II study</td>
<td align="left" colspan="1" rowspan="1">Improvement on NIHSS of ≥ 4 points or a score ≤ 1 at day 14</td>
<td align="left" colspan="1" rowspan="1">236</td>
<td align="left" colspan="2" rowspan="1">
<p>60 Patients (0.1 mg/kg)</p>
<p>57 Patients (0.25 mg/kg)</p>
<p>60 Patients (0.32 g/kg)</p>
<p>To a maximum dose 40 mg</p>
</td>
<td align="left" colspan="1" rowspan="1">59</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</td>
<td align="left" colspan="1" rowspan="1">Multicenter, randomized, open-label, blinded endpoint, phase 3 study</td>
<td align="left" colspan="1" rowspan="1">A reduction in NIHSS score of at least 4 points at 24 h compared with baseline</td>
<td align="left" colspan="1" rowspan="1">204</td>
<td align="left" colspan="1" rowspan="1">100</td>
<td align="left" colspan="1" rowspan="1">0·4 mg/kg up to a maximum of 40 mg</td>
<td align="left" colspan="1" rowspan="1">104</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Bivard [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]</td>
<td align="left" colspan="1" rowspan="1">
<p>Randomized,</p>
<p>open-label, blinded endpoint, phase 2 trial</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">104</td>
<td align="left" colspan="1" rowspan="1">55</td>
<td align="left" colspan="1" rowspan="1">(0·25 mg/kg [maximum 25 mg]</td>
<td align="left" colspan="1" rowspan="1">49</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wang [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</td>
<td align="left" colspan="1" rowspan="1">
<p>A phase 3, multicenter, prospective,</p>
<p>open-label, blinded-endpoint, randomized controlled, non-inferiority trial</p>
</td>
<td align="left" colspan="1" rowspan="1">Decrease of at least 4 points, a score no more than 1 at 24 h and at 7 days, or discharge, whichever occurred first</td>
<td align="left" colspan="1" rowspan="1">1417</td>
<td align="left" colspan="1" rowspan="1">710</td>
<td align="left" colspan="1" rowspan="1">(0·25 mg/kg, maximum dose of 25 mg)</td>
<td align="left" colspan="1" rowspan="1">707</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Parsons [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
<td align="left" colspan="1" rowspan="1">A phase 3, multicenter, randomized, prospective, open-label, masked endpoint, noninferiority clinical trial</td>
<td align="left" colspan="1" rowspan="1">A reduction of at least 8 points or a score of 0 or 1 on the National Institutes of Health Stroke Scale (NIHSS) at 24 h</td>
<td align="left" colspan="1" rowspan="1">680</td>
<td align="left" colspan="1" rowspan="1">339</td>
<td align="left" colspan="1" rowspan="1">0·25 mg/kg bodyweight (maximum dose of 25 mg)</td>
<td align="left" colspan="1" rowspan="1">341</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Meng [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]</td>
<td align="left" colspan="1" rowspan="1">A multicenter, active-controlled, parallel group, randomized, open-label, blinded end point, phase 3 noninferiority study</td>
<td align="left" colspan="1" rowspan="1">NIHSS score of 0 or at least a 4-point improvement from baseline</td>
<td align="left" colspan="1" rowspan="1">1465</td>
<td align="left" colspan="1" rowspan="1">732</td>
<td align="left" colspan="1" rowspan="1">0.25 mg/kg; maximum dose, 25 mg</td>
<td align="left" colspan="1" rowspan="1">733</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Muir [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</td>
<td align="left" colspan="1" rowspan="1">Randomized, parallel group, open-label trial</td>
<td align="left" colspan="1" rowspan="1">An improvement of 8 or more points or a return to a total score of 0 or 1 points on the NIHSS</td>
<td align="left" colspan="1" rowspan="1">1777</td>
<td align="left" colspan="1" rowspan="1">885</td>
<td align="left" colspan="1" rowspan="1">0.25 mg/kg; maximum dose, 25 mg</td>
<td align="left" colspan="1" rowspan="1">892</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p32"><p><sup>*</sup>Standard alteplase dose is0.9 mg/kg (maximum 90 mg), 10% as an initial bolus followed by infusion over 1 h</p></div></div></section><p id="Par25">The primary safety outcomes were symptomatic intracranial hemorrhage (sICH) within 24, 36, and 48 h, as well as all mortality rates at 3 months. Symptomatic intracranial hemorrhage was defined according to the European Cooperative Acute Stroke Study III criteria (ECASS III) as any hemorrhage associated with neurological deterioration, indicated by an increase in the National Institutes of Health Stroke Scale (NIHSS) score of at least 4 points or more, or death, with hemorrhage being identified as the predominant cause of death or worsening [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par26">Other outcomes included favorable functional outcomes, defined as mRS scores of 0–2 at 3 months; poor functional outcomes, defined as mRS scores of 5–6 at 3 months; and any intracranial hemorrhage at 24 and 48 h, defined as any hemorrhage transformation or parenchymal hematoma, according to the European Cooperative Acute Stroke Study I criteria (ECASS I) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Quality assessment and statistical analysis</h3>
<p id="Par27">Since all the studies were RCTs, two independent reviewers (AM and MA) used the Risk of Bias 2 (RoB 2) tool [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>] developed by the Cochrane Collaboration, to assess the risk of bias. Any conflicts between the reviewers were resolved by consensus.</p>
<p id="Par28">We used Review Manager software (RevMan) version 5.4 and comprehensive meta-analysis (CMA) version 3.7z to conduct the meta-analysis. We used the Risk ratio (RR) with a 95% confidence interval (95% CI) to perform Mantel–Haenszel effect size weighting studies. A random effects model by DerSimonian and Laird [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] was used to calculate pooled estimates due to variation in the study setting and the inclusion criteria. Interstudy heterogeneity was measured by I<sup>2</sup> and Cochran's Q test values, with a Cochran's Q p value ≤ 0.1 considered significant for heterogeneity. I<sup>2</sup> values of 25%, 50%, and 75% were considered low, moderate, and high degrees of heterogeneity, respectively.</p>
<p id="Par29">A leave-one-out test was used to address heterogeneity and assess the effectiveness of removing a single study on the significance of the outcome.</p>
<p id="Par30">Subgroup analysis was performed on the basis of the tenecteplase group, and we assessed the major neurological improvements in the study setting. In addition, because most studies used 0.25 mg/kg tenecteplase, we further performed a separate analysis for this dose.</p>
<p id="Par31">Publication bias was assessed via a funnel plot and Egger’s test, with a P value ≤ 0.05 considered significant for publication bias, and any bias was solved via the trim and fill test.</p>
<p id="Par32">On-model meta-regression was used for outcomes from more than 10 studies to assess the effects of mean age, mean NIHSS scores sex and hypertension on the tenecteplase safety and efficacy profile.</p></section></section><section id="Sec6"><h2 class="pmc_sec_title">Results</h2>
<p id="Par33">We searched the database until 17th November 2024, revealing 1209 publications, which reached 741 after removing duplications. After title and abstract screening, 102 articles were subjected to the full-text screening, resulting in 13 RCTs that met the inclusion criteria [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>–<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. The most notable causes of exclusion were incorrect study designs and protocols. Figure <a href="#Fig1" class="usa-link">1</a> shows the PRISMA 2020 flowchart, which summarizes the selection process.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333306_40001_2025_2983_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3235/12333306/7753edfb9a99/40001_2025_2983_Fig1_HTML.jpg" loading="lazy" id="MO1" height="986" width="749" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>PRISMA flow chart for selecting articles process</p></figcaption></figure><section id="Sec7"><h3 class="pmc_sec_title">Characteristics of the selected articles</h3>
<p id="Par34">Among the 13 RCTs, the total number of patients was 9053, of which 4416 received alteplase and 4637 received Tenecteplase. Table <a href="#Tab1" class="usa-link">1</a> summarizes the included studies. Twelve studies were open-label randomized clinical trials with blind endpoints, whereas Heley 2010 [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>] was a double-blinded randomized controlled trial. Studies used different types of randomizations; most of them used block randomization, but a few used stratifications, and a mix of randomization and minimization. The smallest study in terms of sample size was Parsons 2012 [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], which included only 75 patients, and the largest was Muir 2024 [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], which included 1777 patients. Most studies have tested 0.25 mg/kg tenecteplase with a maximum dose of 25 mg [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]; however, some studies have tested 0.4 mg/kg TNK [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], and others have tested 0.1 mg/kg [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>] and 0.32 mg/kg TNK [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. The inclusion criteria and summary of the results are provided in Table S1 in the supplemental materials.</p>
<p id="Par35">Table <a href="#Tab2" class="usa-link">2</a> summarizes the characteristics of the patients included. The overall mean and standard deviation of the age were 69.72 ± 13.4 and for the tenecteplase group and 69.31 ± 13.4 for the alteplase group. The median and interquartile range (IQR) of the baseline NIHSS score were also very similar between the intervention and control groups. In addition, the prestroke modified Rankin scores were typically between 0 and 1. The most common risk factors were hypertension and lipid disorders.
</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Baseline characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="3" colspan="1">Study ID</th>
<th align="left" rowspan="3" colspan="1">Study group</th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="4" rowspan="1">Premorbid modified Rankin Scale score (mRS)</th>
<th align="left" colspan="2" rowspan="1"></th>
<th align="left" colspan="5" rowspan="1">Risk factors</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Age</th>
<th align="left" colspan="1" rowspan="1">Sex (Males)</th>
<th align="left" colspan="1" rowspan="1">Baseline NIHSS score</th>
<th align="left" colspan="1" rowspan="1">0</th>
<th align="left" colspan="1" rowspan="1">1</th>
<th align="left" colspan="1" rowspan="1">2</th>
<th align="left" colspan="1" rowspan="1"> ≥ 3</th>
<th align="left" colspan="1" rowspan="1">Onset-to-needle time (min)</th>
<th align="left" colspan="1" rowspan="1">Door-to-needle time (min)</th>
<th align="left" colspan="1" rowspan="1">HTN</th>
<th align="left" colspan="1" rowspan="1">Diabetes</th>
<th align="left" colspan="1" rowspan="1">Hyperlipidemia/cholesterolemia</th>
<th align="left" colspan="1" rowspan="1">Atrial fibrillation/Arrhythmia</th>
<th align="left" colspan="1" rowspan="1">Smoking</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Mean (SD)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">Median (IQR)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">Median (IQR)</th>
<th align="left" colspan="1" rowspan="1">Median (IQR)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="4" colspan="1">Haley [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.1 mg/kg</td>
<td align="left" colspan="1" rowspan="1">67 (19)</td>
<td align="left" colspan="1" rowspan="1">12(39%)</td>
<td align="left" colspan="1" rowspan="1">8(5–11)</td>
<td align="left" colspan="2" rowspan="1">24(77%)</td>
<td align="left" colspan="2" rowspan="1">7(23%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">25(81%)</td>
<td align="left" colspan="1" rowspan="1">6(19%)</td>
<td align="left" colspan="1" rowspan="1">16(52%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">2(6.5%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK 0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">69(15)</td>
<td align="left" colspan="1" rowspan="1">16(52%)</td>
<td align="left" colspan="1" rowspan="1">10(6–15)</td>
<td align="left" colspan="2" rowspan="1">28(90%)</td>
<td align="left" colspan="2" rowspan="1">3(10%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">25(81%)</td>
<td align="left" colspan="1" rowspan="1">7(23%)</td>
<td align="left" colspan="1" rowspan="1">15(48%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">7(23%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK 0.4 mg/kg</td>
<td align="left" colspan="1" rowspan="1">68 (16)</td>
<td align="left" colspan="1" rowspan="1">13(68%)</td>
<td align="left" colspan="1" rowspan="1">9(5–17)</td>
<td align="left" colspan="2" rowspan="1">19(100%)</td>
<td align="left" colspan="2" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">17(90%)</td>
<td align="left" colspan="1" rowspan="1">4(21%)</td>
<td align="left" colspan="1" rowspan="1">8(42%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA 0.9 mg/kg</td>
<td align="left" colspan="1" rowspan="1">72(16)</td>
<td align="left" colspan="1" rowspan="1">17(51%)</td>
<td align="left" colspan="1" rowspan="1">13(5–17)</td>
<td align="left" colspan="2" rowspan="1">26(84%)</td>
<td align="left" colspan="2" rowspan="1">5(16%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">22(71%)</td>
<td align="left" colspan="1" rowspan="1">4(13%)</td>
<td align="left" colspan="1" rowspan="1">17(55%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">7(23%)</td>
</tr>
<tr>
<td align="left" rowspan="3" colspan="1">Parsons [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.1 mg/kg</td>
<td align="left" colspan="1" rowspan="1">72(6.9)</td>
<td align="left" colspan="1" rowspan="1">13(52%)</td>
<td align="left" colspan="1" rowspan="1">14.5(3.105)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">16(24%)</td>
<td align="left" colspan="1" rowspan="1">8(32%)</td>
<td align="left" colspan="1" rowspan="1">13(52%)</td>
<td align="left" colspan="1" rowspan="1">9(36%)</td>
<td align="left" colspan="1" rowspan="1">9(36%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">68(9.4)</td>
<td align="left" colspan="1" rowspan="1">13(52%)</td>
<td align="left" colspan="1" rowspan="1">14.6(3.105)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">16(24%)</td>
<td align="left" colspan="1" rowspan="1">6(24%)</td>
<td align="left" colspan="1" rowspan="1">15(60%)</td>
<td align="left" colspan="1" rowspan="1">13(52%)</td>
<td align="left" colspan="1" rowspan="1">5(20%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">70(8.4)</td>
<td align="left" colspan="1" rowspan="1">12(48%)</td>
<td align="left" colspan="1" rowspan="1">14(3.105)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">15(60%)</td>
<td align="left" colspan="1" rowspan="1">1(4%)</td>
<td align="left" colspan="1" rowspan="1">9(36%)</td>
<td align="left" colspan="1" rowspan="1">6(24%)</td>
<td align="left" colspan="1" rowspan="1">1(4%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Huang [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">71(13)</td>
<td align="left" colspan="1" rowspan="1">30(64%)</td>
<td align="left" colspan="1" rowspan="1">12(9–18)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">180(156–215)</td>
<td align="left" colspan="1" rowspan="1">42(22.95)</td>
<td align="left" colspan="1" rowspan="1">20(43%)</td>
<td align="left" colspan="1" rowspan="1">7(15%)</td>
<td align="left" colspan="1" rowspan="1">4(9%)</td>
<td align="left" colspan="1" rowspan="1">19(40%)</td>
<td align="left" colspan="1" rowspan="1">13(28%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">71(12)</td>
<td align="left" colspan="1" rowspan="1">31(63%)</td>
<td align="left" colspan="1" rowspan="1">11(8–16)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">200(160–220)</td>
<td align="left" colspan="1" rowspan="1">38(25.65)</td>
<td align="left" colspan="1" rowspan="1">28(57%)</td>
<td align="left" colspan="1" rowspan="1">7(14%)</td>
<td align="left" colspan="1" rowspan="1">7(14%)</td>
<td align="left" colspan="1" rowspan="1">15(31%)</td>
<td align="left" colspan="1" rowspan="1">10(20%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.4 mg/kg</td>
<td align="left" colspan="1" rowspan="1">70.8(14.4)</td>
<td align="left" colspan="1" rowspan="1">321(58%)</td>
<td align="left" colspan="1" rowspan="1">4(2–7)</td>
<td align="left" colspan="1" rowspan="1">435(79%)</td>
<td align="left" colspan="1" rowspan="1">62(11%)</td>
<td align="left" colspan="1" rowspan="1">25(5%)</td>
<td align="left" colspan="1" rowspan="1">27(5%)</td>
<td align="left" colspan="1" rowspan="1">118(79–180)</td>
<td align="left" colspan="1" rowspan="1">32(22–47)</td>
<td align="left" colspan="1" rowspan="1">246(45%)</td>
<td align="left" colspan="1" rowspan="1">72(13%)</td>
<td align="left" colspan="1" rowspan="1">61(11%)</td>
<td align="left" colspan="1" rowspan="1">50(9%)</td>
<td align="left" colspan="1" rowspan="1">169(31%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">71.2(13.2)</td>
<td align="left" colspan="1" rowspan="1">339(62%)</td>
<td align="left" colspan="1" rowspan="1">4(2–8)</td>
<td align="left" colspan="1" rowspan="1">425(77%)</td>
<td align="left" colspan="1" rowspan="1">65(12%)</td>
<td align="left" colspan="1" rowspan="1">26(5%)</td>
<td align="left" colspan="1" rowspan="1">35(6%)</td>
<td align="left" colspan="1" rowspan="1">111(80–174)</td>
<td align="left" colspan="1" rowspan="1">34(25–50)</td>
<td align="left" colspan="1" rowspan="1">236(43%)</td>
<td align="left" colspan="1" rowspan="1">74(13%)</td>
<td align="left" colspan="1" rowspan="1">65(12%)</td>
<td align="left" colspan="1" rowspan="1">69(13%)</td>
<td align="left" colspan="1" rowspan="1">177(32%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Campbell [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">70.4(15.1)</td>
<td align="left" colspan="1" rowspan="1">58(57%)</td>
<td align="left" colspan="1" rowspan="1">17(12–22)</td>
<td align="left" colspan="1" rowspan="1">76(75%)</td>
<td align="left" colspan="1" rowspan="1">15(15%)</td>
<td align="left" colspan="1" rowspan="1">3(3%)</td>
<td align="left" colspan="1" rowspan="1">7(7%)</td>
<td align="left" colspan="1" rowspan="1">125(102–156)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">64(63%)</td>
<td align="left" colspan="1" rowspan="1">10(10%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">27(27%)</td>
<td align="left" colspan="1" rowspan="1">18(18%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">71.9(13.7)</td>
<td align="left" colspan="1" rowspan="1">52(51%)</td>
<td align="left" colspan="1" rowspan="1">17(12–22)</td>
<td align="left" colspan="1" rowspan="1">81(80%)</td>
<td align="left" colspan="1" rowspan="1">6(6%)</td>
<td align="left" colspan="1" rowspan="1">2(2%)</td>
<td align="left" colspan="1" rowspan="1">12(12%)</td>
<td align="left" colspan="1" rowspan="1">134(104–176)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">63(62%)</td>
<td align="left" colspan="1" rowspan="1">18(18%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">40(40%)</td>
<td align="left" colspan="1" rowspan="1">11(11%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Menon [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK</td>
<td align="left" colspan="1" rowspan="1">74(14.81)</td>
<td align="left" colspan="1" rowspan="1">424(52.6%)</td>
<td align="left" colspan="1" rowspan="1">9(6–16)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">128(93–186)</td>
<td align="left" colspan="1" rowspan="1">36(27–49)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">73(14.81)</td>
<td align="left" colspan="1" rowspan="1">398(51.6%)</td>
<td align="left" colspan="1" rowspan="1">10(6–17)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">131(95–188)</td>
<td align="left" colspan="1" rowspan="1">37(29–52)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">Li [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.1 mg/kg</td>
<td align="left" colspan="1" rowspan="1">62.4(11.1)</td>
<td align="left" colspan="1" rowspan="1">48(80%)</td>
<td align="left" colspan="1" rowspan="1">7(5.0–10.0)</td>
<td align="left" colspan="1" rowspan="1">55(91.7%)</td>
<td align="left" colspan="1" rowspan="1">5(8.3%)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">154(56–195)</td>
<td align="left" colspan="1" rowspan="1">71(28–149)</td>
<td align="left" colspan="1" rowspan="1">43(71.7%)</td>
<td align="left" colspan="1" rowspan="1">14(23.3%)</td>
<td align="left" colspan="1" rowspan="1">17(28.3%)</td>
<td align="left" colspan="1" rowspan="1">8(13.3%)</td>
<td align="left" colspan="1" rowspan="1">25(41.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK 0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">64.3(12.8)</td>
<td align="left" colspan="1" rowspan="1">42(73.7%)</td>
<td align="left" colspan="1" rowspan="1">8(5.0–12.0)</td>
<td align="left" colspan="1" rowspan="1">54(94.7%)</td>
<td align="left" colspan="1" rowspan="1">3(5.3%)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">149(80–179)</td>
<td align="left" colspan="1" rowspan="1">60(5–180)</td>
<td align="left" colspan="1" rowspan="1">37(64.9%)</td>
<td align="left" colspan="1" rowspan="1">9(15.8%)</td>
<td align="left" colspan="1" rowspan="1">13(22.8%)</td>
<td align="left" colspan="1" rowspan="1">4(7%)</td>
<td align="left" colspan="1" rowspan="1">25(43.9%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK 0.32 mg/kg</td>
<td align="left" colspan="1" rowspan="1">64.8(12.1)</td>
<td align="left" colspan="1" rowspan="1">42(70%)</td>
<td align="left" colspan="1" rowspan="1">7.5(6.0–12.0)</td>
<td align="left" colspan="1" rowspan="1">47(78.3%)</td>
<td align="left" colspan="1" rowspan="1">11(18.3%)</td>
<td align="left" colspan="1" rowspan="1">2(3.3%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">147(69–220)</td>
<td align="left" colspan="1" rowspan="1">69(10–134)</td>
<td align="left" colspan="1" rowspan="1">35(58.3%)</td>
<td align="left" colspan="1" rowspan="1">15(25%)</td>
<td align="left" colspan="1" rowspan="1">10(16.7%)</td>
<td align="left" colspan="1" rowspan="1">14(23.3%)</td>
<td align="left" colspan="1" rowspan="1">21(35%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">66.5(12.6)</td>
<td align="left" colspan="1" rowspan="1">38(64.4%)</td>
<td align="left" colspan="1" rowspan="1">8(5.0–12.0)</td>
<td align="left" colspan="1" rowspan="1">50(84.8%)</td>
<td align="left" colspan="1" rowspan="1">5(8.5%)</td>
<td align="left" colspan="1" rowspan="1">4(6.8%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">153(18–187)</td>
<td align="left" colspan="1" rowspan="1">71(10–146)</td>
<td align="left" colspan="1" rowspan="1">42(71.2%)</td>
<td align="left" colspan="1" rowspan="1">11(18.6%)</td>
<td align="left" colspan="1" rowspan="1">11(18.6%)</td>
<td align="left" colspan="1" rowspan="1">6(10.2%)</td>
<td align="left" colspan="1" rowspan="1">24(40.7%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK 0.4 mg/kg</td>
<td align="left" colspan="1" rowspan="1">73·2(12·6)</td>
<td align="left" colspan="1" rowspan="1">45(45%)</td>
<td align="left" colspan="1" rowspan="1">11·5(8–17)</td>
<td align="left" colspan="1" rowspan="1">60(60·0%)</td>
<td align="left" colspan="1" rowspan="1">25(25%)</td>
<td align="left" colspan="1" rowspan="1">11(11%)</td>
<td align="left" colspan="1" rowspan="1">4(4%)</td>
<td align="left" colspan="1" rowspan="1">92·5(74–143)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">56(56%)</td>
<td align="left" colspan="1" rowspan="1">17(17%)</td>
<td align="left" colspan="1" rowspan="1">30(30%)</td>
<td align="left" colspan="1" rowspan="1">9(9%)</td>
<td align="left" colspan="1" rowspan="1">24(24%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">68·6(15·6)</td>
<td align="left" colspan="1" rowspan="1">53(51%)</td>
<td align="left" colspan="1" rowspan="1">11(8–17·5)</td>
<td align="left" colspan="1" rowspan="1">76(73·1%)</td>
<td align="left" colspan="1" rowspan="1">19(18.3%)</td>
<td align="left" colspan="1" rowspan="1">7(6.7%)</td>
<td align="left" colspan="1" rowspan="1">2(1.9%)</td>
<td align="left" colspan="1" rowspan="1">99(73–143)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">48(46%)</td>
<td align="left" colspan="1" rowspan="1">11(11%)</td>
<td align="left" colspan="1" rowspan="1">33(32%)</td>
<td align="left" colspan="1" rowspan="1">8(8%)</td>
<td align="left" colspan="1" rowspan="1">25(24%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Bivard [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">73.33(18.27)</td>
<td align="left" colspan="1" rowspan="1">33(60%)</td>
<td align="left" colspan="1" rowspan="1">8(5–14)</td>
<td align="left" colspan="1" rowspan="1">47(85%)</td>
<td align="left" colspan="1" rowspan="1">4(7%)</td>
<td align="left" colspan="1" rowspan="1">1(2%)</td>
<td align="left" colspan="1" rowspan="1">3(5%)</td>
<td align="left" colspan="1" rowspan="1">97(68–157)</td>
<td align="left" colspan="1" rowspan="1">30(25–38)</td>
<td align="left" colspan="1" rowspan="1">30(55%)</td>
<td align="left" colspan="1" rowspan="1">11(30%)</td>
<td align="left" colspan="1" rowspan="1">21(38%)</td>
<td align="left" colspan="1" rowspan="1">8,54(15%)</td>
<td align="left" colspan="1" rowspan="1">8,54(15%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">71.33(14.51)</td>
<td align="left" colspan="1" rowspan="1">30(61%)</td>
<td align="left" colspan="1" rowspan="1">8(5–17)</td>
<td align="left" colspan="1" rowspan="1">39(80%)</td>
<td align="left" colspan="1" rowspan="1">1(2%)</td>
<td align="left" colspan="1" rowspan="1">3(6%)</td>
<td align="left" colspan="1" rowspan="1">6(12%)</td>
<td align="left" colspan="1" rowspan="1">92(66–31)</td>
<td align="left" colspan="1" rowspan="1">37(32–43)</td>
<td align="left" colspan="1" rowspan="1">31(63%)</td>
<td align="left" colspan="1" rowspan="1">17/48(35%)</td>
<td align="left" colspan="1" rowspan="1">22(45%)</td>
<td align="left" colspan="1" rowspan="1">7,48(15%)</td>
<td align="left" colspan="1" rowspan="1">9(18%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Wang [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">66.00(11.14)</td>
<td align="left" colspan="1" rowspan="1">492(69%)</td>
<td align="left" colspan="1" rowspan="1">7(5–10)</td>
<td align="left" colspan="1" rowspan="1">634(89%)</td>
<td align="left" colspan="1" rowspan="1">76(11%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">180(135–222)</td>
<td align="left" colspan="1" rowspan="1">58(45–78)</td>
<td align="left" colspan="1" rowspan="1">510(72%)</td>
<td align="left" colspan="1" rowspan="1">172(24%)</td>
<td align="left" colspan="1" rowspan="1">130(18%)</td>
<td align="left" colspan="1" rowspan="1">137(19%)</td>
<td align="left" colspan="1" rowspan="1">266(38%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">65.00(10.4)</td>
<td align="left" colspan="1" rowspan="1">479(68%)</td>
<td align="left" colspan="1" rowspan="1">7(6–10)</td>
<td align="left" colspan="1" rowspan="1">633(85.5%)</td>
<td align="left" colspan="1" rowspan="1">74(10.5%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">178·5(135–230)</td>
<td align="left" colspan="1" rowspan="1">61(48–84)</td>
<td align="left" colspan="1" rowspan="1">512(72%)</td>
<td align="left" colspan="1" rowspan="1">207(29%)</td>
<td align="left" colspan="1" rowspan="1">160(23%)</td>
<td align="left" colspan="1" rowspan="1">146(21%)</td>
<td align="left" colspan="1" rowspan="1">276(39%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Parsons [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">74(12.66)</td>
<td align="left" colspan="1" rowspan="1">202(60%)</td>
<td align="left" colspan="1" rowspan="1">7(4–11)</td>
<td align="left" colspan="1" rowspan="1">285(84%)</td>
<td align="left" colspan="1" rowspan="1">54(16%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">151(120–189)</td>
<td align="left" colspan="1" rowspan="1">65(48–86)</td>
<td align="left" colspan="1" rowspan="1">218(64%)</td>
<td align="left" colspan="1" rowspan="1">58(19.7%)</td>
<td align="left" colspan="1" rowspan="1">122(41.4%)</td>
<td align="left" colspan="1" rowspan="1">62(18%)</td>
<td align="left" colspan="1" rowspan="1">50(16.9%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">72.33(13.4)</td>
<td align="left" colspan="1" rowspan="1">218(64%)</td>
<td align="left" colspan="1" rowspan="1">7(5–10)</td>
<td align="left" colspan="1" rowspan="1">297(87%)</td>
<td align="left" colspan="1" rowspan="1">44(13%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">155(125–199)</td>
<td align="left" colspan="1" rowspan="1">64(50–85)</td>
<td align="left" colspan="1" rowspan="1">210(62%)</td>
<td align="left" colspan="1" rowspan="1">57(18.7%)</td>
<td align="left" colspan="1" rowspan="1">116(38%)</td>
<td align="left" colspan="1" rowspan="1">66(19%)</td>
<td align="left" colspan="1" rowspan="1">47(15.4%)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Meng [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">65.67(11.14)</td>
<td align="left" colspan="1" rowspan="1">517(70.6%)</td>
<td align="left" colspan="1" rowspan="1">6(5.0–8.5)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">199(27.2%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">108(14.8%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">65(11.88)</td>
<td align="left" colspan="1" rowspan="1">502(68.5%)</td>
<td align="left" colspan="1" rowspan="1">6(5.0–9.0)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">204(27.8%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">97(13.2%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Muir [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]</td>
<td align="left" colspan="1" rowspan="1">TNK0.25 mg/kg</td>
<td align="left" colspan="1" rowspan="1">70.4(12.5)</td>
<td align="left" colspan="1" rowspan="1">533(60%)</td>
<td align="left" colspan="1" rowspan="1">7(5–13)</td>
<td align="left" colspan="1" rowspan="1">660(75%)</td>
<td align="left" colspan="1" rowspan="1">182(21%)</td>
<td align="left" colspan="1" rowspan="1">43(5%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">143(115–188)</td>
<td align="left" colspan="1" rowspan="1">47(34–62)</td>
<td align="left" colspan="1" rowspan="1">461(552%)</td>
<td align="left" colspan="1" rowspan="1">157(18%)</td>
<td align="left" colspan="1" rowspan="1">245(28%)</td>
<td align="left" colspan="1" rowspan="1">95(11%)</td>
<td align="left" colspan="1" rowspan="1">180(20%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rtPA</td>
<td align="left" colspan="1" rowspan="1">70.4(13.4)</td>
<td align="left" colspan="1" rowspan="1">527(59%)</td>
<td align="left" colspan="1" rowspan="1">7(5–12)</td>
<td align="left" colspan="1" rowspan="1">625(70%)</td>
<td align="left" colspan="1" rowspan="1">202(23%)</td>
<td align="left" colspan="1" rowspan="1">65(7&amp;)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">147(113–185)</td>
<td align="left" colspan="1" rowspan="1">46(36–58)</td>
<td align="left" colspan="1" rowspan="1">466(52%)</td>
<td align="left" colspan="1" rowspan="1">141(16%)</td>
<td align="left" colspan="1" rowspan="1">259(29%)</td>
<td align="left" colspan="1" rowspan="1">92(10%)</td>
<td align="left" colspan="1" rowspan="1">170(19%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec8"><h3 class="pmc_sec_title">Quality assessment</h3>
<p id="Par36">Six studies [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>] had a low risk of bias, whereas the remaining 7 had some concerns [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. This appears to be due to randomization errors or deviation from the intended intervention. For Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], an observed difference in patients’ baseline characteristics was found between the two groups, and in Haley [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>], two patients were not randomized, resulting in an error in the randomization process in both studies. In other studies, few patients were assigned to take one drug but actually received the comparator drug, which led to a deviation from the intended intervention [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. See Fig. <a href="#Fig1" class="usa-link">1</a> supplementary material.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Study outcomes</h3>
<section id="Sec10"><h4 class="pmc_sec_title">Efficacy outcomes</h4>
<p id="Par37">For the primary endpoints, patients taking 0.25 mg/kg TNK had higher rates of excellent functional outcomes than those taking alteplase did (RR: 1.06, 95% CI (1.01–1.1), p = 0.01, I<sup>2</sup> 0% and P for Cochrane Q 0.79), however, there was no difference between the two groups in achieving major neurological improvement. (RR: 1.04 95% CI (0.98–1.11), P value 0.23, I<sup>2</sup> 18% and P for Cochrane Q 0.29). See Fig. <a href="#Fig2" class="usa-link">2</a> and Table <a href="#Tab3" class="usa-link">3</a>.</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333306_40001_2025_2983_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3235/12333306/69039e9d8866/40001_2025_2983_Fig2_HTML.jpg" loading="lazy" id="MO2" height="954" width="684" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot TNK 0.25 mg/kg vs alteplase in a/Excellent functional outcome (mRS 0–1 at 90 days), b/death at 90 days and c/symptomatic intracranial hemorrhage (sICH)</p></figcaption></figure><section class="tw xbox font-sm" id="Tab3"><h5 class="obj_head">Table 3.</h5>
<div class="caption p"><p>Summary of meta-analysis results</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Outcome</th>
<th align="left" colspan="1" rowspan="1">No studies</th>
<th align="left" colspan="1" rowspan="1">No patients in the intervention group</th>
<th align="left" colspan="1" rowspan="1">No patients in the control group</th>
<th align="left" colspan="1" rowspan="1">Risk ratio (RR)</th>
<th align="left" colspan="1" rowspan="1">95%CI</th>
<th align="left" colspan="1" rowspan="1">P value</th>
<th align="left" colspan="1" rowspan="1">I<sup>2</sup>
</th>
<th align="left" colspan="1" rowspan="1">P Cochran Q</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="9" rowspan="1">TNK 0.25 mg vs alteplase</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> MNI</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">2884</td>
<td align="left" colspan="1" rowspan="1">2890</td>
<td align="center" colspan="1" rowspan="1">1.04</td>
<td align="left" colspan="1" rowspan="1">(0.98–1.11)</td>
<td align="center" colspan="1" rowspan="1">0.23</td>
<td align="left" colspan="1" rowspan="1">18%</td>
<td align="left" colspan="1" rowspan="1">0.29</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (0–1)</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">3735</td>
<td align="left" colspan="1" rowspan="1">3697</td>
<td align="center" colspan="1" rowspan="1">1.06</td>
<td align="left" colspan="1" rowspan="1">(1.01–1.1)</td>
<td align="center" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1">0.79</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (0–2)</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">3657</td>
<td align="left" colspan="1" rowspan="1">3617</td>
<td align="center" colspan="1" rowspan="1">1.03</td>
<td align="left" colspan="1" rowspan="1">(0.99–1.07)</td>
<td align="center" colspan="1" rowspan="1">0.17</td>
<td align="left" colspan="1" rowspan="1">35%</td>
<td align="left" colspan="1" rowspan="1">0.14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (5–6)</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">843</td>
<td align="left" colspan="1" rowspan="1">838</td>
<td align="center" colspan="1" rowspan="1">0.85</td>
<td align="left" colspan="1" rowspan="1">(0.63–1.15)</td>
<td align="center" colspan="1" rowspan="1">0.29</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1">0.41</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Death</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">3774</td>
<td align="left" colspan="1" rowspan="1">3774</td>
<td align="center" colspan="1" rowspan="1">0.97</td>
<td align="left" colspan="1" rowspan="1">(0.82–1.15)</td>
<td align="center" colspan="1" rowspan="1">0.71</td>
<td align="left" colspan="1" rowspan="1">12%</td>
<td align="left" colspan="1" rowspan="1">0.33</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> sICH</td>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">3730</td>
<td align="left" colspan="1" rowspan="1">3702</td>
<td align="center" colspan="1" rowspan="1">1.12</td>
<td align="left" colspan="1" rowspan="1">(0.83–1.52)</td>
<td align="center" colspan="1" rowspan="1">0.47</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1">.97</td>
</tr>
<tr><td align="left" colspan="9" rowspan="1">TNK 0.1 mg vs alteplase</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (0–1)</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="left" colspan="1" rowspan="1">115</td>
<td align="center" colspan="1" rowspan="1">0.95</td>
<td align="left" colspan="1" rowspan="1">(0.74–1.23)</td>
<td align="center" colspan="1" rowspan="1">0.7</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1">0.89</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Death</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="left" colspan="1" rowspan="1">115</td>
<td align="center" colspan="1" rowspan="1">0.67</td>
<td align="left" colspan="1" rowspan="1">(0.29–1.59)</td>
<td align="center" colspan="1" rowspan="1">0.37</td>
<td align="left" colspan="1" rowspan="1">21%</td>
<td align="left" colspan="1" rowspan="1">0.28</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> sICH</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="left" colspan="1" rowspan="1">115</td>
<td align="center" colspan="1" rowspan="1">0.78</td>
<td align="left" colspan="1" rowspan="1">(0.18–3.45)</td>
<td align="center" colspan="1" rowspan="1">0.74</td>
<td align="left" colspan="1" rowspan="1">10%</td>
<td align="left" colspan="1" rowspan="1">0.33</td>
</tr>
<tr><td align="left" colspan="9" rowspan="1">TNK 0.4 mg vs alteplase</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> MNI</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">668</td>
<td align="left" colspan="1" rowspan="1">686</td>
<td align="center" colspan="1" rowspan="1">0.93</td>
<td align="left" colspan="1" rowspan="1">(0.68–1.28)</td>
<td align="center" colspan="1" rowspan="1">0.66</td>
<td align="left" colspan="1" rowspan="1">72%</td>
<td align="left" colspan="1" rowspan="1">0.03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (0–1)</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">668</td>
<td align="left" colspan="1" rowspan="1">686</td>
<td align="center" colspan="1" rowspan="1">0.84</td>
<td align="left" colspan="1" rowspan="1">(0.57–1.24)</td>
<td align="center" colspan="1" rowspan="1">0.38</td>
<td align="left" colspan="1" rowspan="1">75%</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Death</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">668</td>
<td align="left" colspan="1" rowspan="1">686</td>
<td align="center" colspan="1" rowspan="1">1.32</td>
<td align="left" colspan="1" rowspan="1">(0.6–2.9)</td>
<td align="center" colspan="1" rowspan="1">0.49</td>
<td align="left" colspan="1" rowspan="1">60%</td>
<td align="left" colspan="1" rowspan="1">0.08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> sICH</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">668</td>
<td align="left" colspan="1" rowspan="1">686</td>
<td align="center" colspan="1" rowspan="1">2.27</td>
<td align="left" colspan="1" rowspan="1">(0.7–7.36)</td>
<td align="center" colspan="1" rowspan="1">0.17</td>
<td align="left" colspan="1" rowspan="1">41%</td>
<td align="left" colspan="1" rowspan="1">0.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Any ICH</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">668</td>
<td align="left" colspan="1" rowspan="1">686</td>
<td align="center" colspan="1" rowspan="1">1.59</td>
<td align="left" colspan="1" rowspan="1">(0.71–3.56)</td>
<td align="center" colspan="1" rowspan="1">0.26</td>
<td align="left" colspan="1" rowspan="1">72%</td>
<td align="left" colspan="1" rowspan="1">0.03</td>
</tr>
<tr><td align="left" colspan="9" rowspan="1">TNK 0.25 mg VS TNK 0.1 mg</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> mRS (0–1)</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">113</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="center" colspan="1" rowspan="1">1.27</td>
<td align="left" colspan="1" rowspan="1">(0.9–1.79)</td>
<td align="center" colspan="1" rowspan="1">0.17</td>
<td align="left" colspan="1" rowspan="1">41%</td>
<td align="left" colspan="1" rowspan="1">0.18</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Death</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">113</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="center" colspan="1" rowspan="1">0.67</td>
<td align="left" colspan="1" rowspan="1">(0.09–4.77)</td>
<td align="center" colspan="1" rowspan="1">0.69</td>
<td align="left" colspan="1" rowspan="1">69%</td>
<td align="left" colspan="1" rowspan="1">0.04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> sICH</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">113</td>
<td align="left" colspan="1" rowspan="1">116</td>
<td align="center" colspan="1" rowspan="1">0.9</td>
<td align="left" colspan="1" rowspan="1">(0.13–6.20)</td>
<td align="center" colspan="1" rowspan="1">0.91</td>
<td align="left" colspan="1" rowspan="1">26%</td>
<td align="left" colspan="1" rowspan="1">0.26</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p50">
<p>mRS (0–1): Excellent functional outcomes</p>
<p>mRS (0–2): Favorable functional outcomes</p>
<p>mRS (5–6): Poor functional outcomes</p>
<p>sICH: symptomatic intracranial hemorrhage</p>
<p>any ICH: any intracranial hemorrhage</p>
</div></div></section><p id="Par38">Subgroup analysis for major neurological improvements based on the study setting revealed no difference between the European and Chinese populations. In both groups, TNK 0.25 mg/kg was slightly better than alteplase with no statistically significant difference (RR 1.03, 95% CI (0.96–1.11), P value 0.41), and (RR 1.04, 95% CI (0.94–1.16), P value 0.45), for both European and Chinese patients. See file 1 in the supplementary materials.</p>
<p id="Par39">Another subgroup analysis for major neurological improvement based on its definition across studies. There was no difference between TNK 0.25 mg/kg and alteplase for both definitions, either a ≥ 8 points reduction or a ≥ 4 points reduction (P values 0.35 and 0.45, respectively). See file 1 in the supplementary materials.</p>
<p id="Par40">TNK 0.25 mg/kg had no statistically significant effect on mortality or symptomatic intracranial hemorrhage rates (sICH) (RR: 0.97, 95% CI (0.82–1.15) P value 0.71, I<sup>2</sup> 12% and P for Cochrane Q 0.33), and (RR: 1.12, 95% CI (0.83–1.52) P value 0.47, I<sup>2</sup> 0% and P for Cochrane Q 0.97). See Fig. <a href="#Fig2" class="usa-link">2</a> and Table <a href="#Tab3" class="usa-link">3</a>.</p>
<p id="Par41">Most studies included patients who would be eligible for mechanical thrombectomy for better interpretation of all patients with acute ischemic stroke; however, Campbell’s 2018 study was based on a comparison between 0.25 mg/kg TNK and alteplase before mechanical thrombectomy, and their results revealed that 0.25 mg/kg TNK was better than alteplase in achieving early recanalization (P value 0.04) with no statistically significant difference in achieving excellent functional outcomes, major neurological improvements, decreased death rates, or symptomatic intracranial hemorrhage (sICH) rates (P values 0.2 and 0.7,0.049 and 0.9, respectively).</p>
<p id="Par42">TNK 0.4 mg/kg had worse safety outcomes than alteplase, as it increased death and symptomatic intracranial hemorrhage rates (RR: 1.32, 95% CI (0.6–2.9) P value 0.49, I<sup>2</sup> 60% and P for Cochrane Q 0.08), (RR: 2.27, 95% CI (0.7–7.36) P value 0.17, I<sup>2</sup> 41% and P for Cochrane Q 0.18). However, with small studies, no definite conclusions can be drawn.</p></section></section><section id="Sec11"><h3 class="pmc_sec_title">Sensitivity analysis</h3>
<p id="Par43">A leave-one-out test was used for all outcomes comparing 0.25 mg/kg TNK with alteplase, revealing that there is no single study that can change the significance of the outcome. (See file 1 supplementary material). However, for major neurological improvement, Parson [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] was a source of heterogeneity as after removing it, Cochran's Q p value changed from 0.03 to 0.29 and I<sup>2</sup> changed from 53 to 18%. This may be because Parsons [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] included patients with stroke up to 12 h after onset. Interestingly, change in the definitions of major neurological improvements did not affect the homogeneity of the studies.</p>
<p id="Par44">In the outcomes that compared 0.1 mg/kg TNK, no single study changed the significance of the results. On the other hand, Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>] appears to be the source of heterogeneity for outcomes comparing TNK 0.4 mg/kg, and removing this study will make the study significant for alteplase; this work for major neurological improvements, excellent functional outcomes, and symptomatic intracranial hemorrhage (sICH), and for death outcomes, Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>] appeared to be the source of heterogeneity. This heterogeneity may be due to the differences in the baseline value of Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>] and Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], as Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>] included patients with a lower mean age than did Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>], and 15% of patients were above 80 years of age in Logallo 2017, whereas 31% for were above 80 years of age in Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Finally, 45% of patients had hypertension and 11% had hypercholesterolemia in Logallo [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], whereas 56% had hypertension and 30% had hypercholesterolemia in Kvistad [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Overall, no studies were excluded because a few small studies compared 0.4 mg/kg TNK with alteplase.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Meta-regression</h3>
<p id="Par45">We conducted a meta-regression assessing the baseline mean NIHSS score, mean age, and sex hypertension on the log risk ratio of outcomes that had 10 studies or more. We found that an increase in the baseline NIHSS score had a statistically significant negative effect on achieving favorable functional outcomes (mRS 0–2) (SE 0.1 95% CI (0.092–0.04) P value 0.025), and a male percentage increase had a negative effect on favorable functional outcomes but with not statistically significant (SE 0.0048 95% CI (− 0.018–0.0009) P value 0.08). See Fig. <a href="#Fig3" class="usa-link">3</a> and file 2 of the supplementary materials.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333306_40001_2025_2983_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3235/12333306/09405df5fb51/40001_2025_2983_Fig3_HTML.jpg" loading="lazy" id="MO3" height="994" width="660" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>bubble plot assesses the association between 1/baseline NIHSS score and mRS0-2 and 2/male sex and mRS 0–2</p></figcaption></figure></section><section id="Sec13"><h3 class="pmc_sec_title">Publication bias</h3>
<p id="Par46">Outcomes with 10 studies or more were assessed for publication bias using a funnel plot and Egger’s test, both of which were generated from the comprehensive meta-analysis version 3.7. No publication bias was observed via the funnel plot, and the results were confirmed by Egger’s test (<em>p</em> values of 0.07, 0.3, and 0.2) for mRS 0–1, death, and sICH, respectively.</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par47">This study is the most up-to-date in assessing the safety and efficacy of TNKs in comparison with alteplase in patients with acute ischemic stroke within 4.5 h of onset.</p>
<p id="Par48">Our findings demonstrate the superiority of 0.25 mg/kg TNK to alteplase in achieving excellent functional outcomes at 90 days and are not inferior in achieving major neurological improvements and favorable functional outcomes, with efficacy favored by 0.25 mg/kg TNK. In addition, 0.25 mg/kg TNK did not significantly reduce death and symptomatic intracranial hemorrhage.</p>
<p id="Par49">On the other hand, our results suggests that 0.1 mg/kg TNK had a greater safety profile than 0.25 mg/kg TNK, and the 0.4 mg/kg TNK had greater incidence of symptomatic intracranial hemorrhage than alteplase did: however, with few studies evaluating these two doses, no conclusion could be drawn.</p>
<p id="Par50">Finally, seven of the thirteen studies had some concerns due to randomization error or deviation from the intended intervention. This puts some restrictions on the significance of the study results. Several randomized controlled trials are needed with a low risk of bias to further assess the safety and efficacy of tenecteplase (TNK) as compared to alteplase to make the results more comprehensive.</p>
<p id="Par51">Our results are similar to those of previous systematic reviews and meta-analyses that compared different doses and different conditions of TNK with alteplase. In Wu et al. 2024, the researchers compared TNK with alteplase in patients undergoing mechanical thrombectomy, and included 10 studies, of which two were RCTs and eight were cohort studies, with 3722 patients in the alteplase group and 1,266 in the TNK group. The results revealed that TNK was superior to alteplase in terms of early recanalization with a reduced death rate and was not inferior in symptomatic intracranial hemorrhage (sICH) [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Another meta-analysis comparing Asian and Caucasian populations included 34 articles between RCTs and cohorts with 59,601 patients; TNK: 12,546 and Alteplase: 47,055 patients reported similar results. The early recanalization rate was high in Asian populations. A comparison of TNK doses revealed that a 0.25 mg/kg dose was associated with excellent functional outcome (mRS 0–1), whereas TNK 0.1 mg/kg was better for early recanalization, major neurological improvement, and symptomatic intracranial hemorrhage (sICH) compared to alteplase [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. The other two meta-analyses, one focused on phase III studies and the other focused on a dose of 0.25 mg/kg, and both had similar results [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Our study introduced more information by performing a meta-regression to determine the relationships between the baseline characteristics of the NIHSS score and sex and the study outcomes.</p>
<p id="Par52">In a previous network meta-analysis, Srisurapanont 2024 compared different doses of TNK vs alteplase, and did not prove the superiority of TNK over alteplase in terms of the mRS score of 0–1, although they also reported no difference in other efficacy outcomes compared with our findings. They did not find statistically significant differences between the two drugs in terms of safety; however, they reported that 0.4 mg/kg TNK was associated with a greater rate of symptomatic intracranial hemorrhage (sICH). They also did not find enough data to compare different doses of TNK, but they suggested that a 0.25 mg/kg dose may be optimal. These results may be because they did not include articles published in 2024 [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>].</p>
<p id="Par53">Several studies have compared TNK with alteplase using real-world data. Warach et al., [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>], focused on symptomatic intracranial hemorrhage (sICH) among 1925 patients in the TNK group and 7313 in the alteplase group and reported a reduction in the number of sICH patients in the TNK group as compared to the alteplase group [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Liu et al. [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>] reported the same endpoint as Warach et al. [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>] did in a study in China, with 1113 patients in the TNK group and 2360 patients in the alteplase group, with a median TNK dose of 0.25 mg/kg. Although they showed that TNK is safe in practice, there are concerns related to their results, as TNK group patients were significantly younger than Alteplase group patients with minor stroke [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Finally, Skärlunda et al. 2024 compared 888 patients receiving 0.4 mg/kg TNK with 6560 alteplase patients, and the findings were consistent with our results that 0.4 mg/kg TNK is inferior to alteplase [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par54">Several trials have compared tenecteplase and alteplase as bridging therapies for mechanical thrombectomy (<a href="https://clinicaltrials.gov/ct2/show/NCT06658197" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06658197</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT04454788" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04454788</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT05105633" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05105633</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT05199194" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05199194</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT06221371" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06221371</a>, and <a href="https://clinicaltrials.gov/ct2/show/NCT05701956" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05701956</a>), and Qiu et al. [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. These trials will enhance the current knowledge for a better understanding of the safety and efficacy of TNK.</p>
<p id="Par55">Other trials have assessed the safety and efficacy of TNKs as intra-arterial injections for large vessel occlusion (<a href="https://clinicaltrials.gov/ct2/show/NCT05657470" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05657470</a>, <a href="https://clinicaltrials.gov/ct2/show/NCT05657444" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05657444</a>, and <a href="https://clinicaltrials.gov/ct2/show/NCT05657457" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05657457</a> [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]). Recently, two trials, Huang 2025 and Hu 2025, have been published discussing intra-arterial TNKs in comparison with controls. Both included 747 patients, of whom 373 patients were treated by intra-arterial TNKs and the remaining patients were in the control group. They reported a slightly higher rate of excellent functional outcomes, with no statistically significant results, however, Huang 2025 reported a statistically significant increase in symptomatic intracranial hemorrhage (sICH) in the TNK group [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Further studies should be conducted to better understand its effect.</p>
<p id="Par56">In addition, several studies have assessed the efficacy of TNK in the extended window; for example, a recent systematic review and meta-analysis of three small sample size RCTs compared TNK versus standard medical treatment for patients with stroke after 4.5 h of onset which showed statistically significant excellent functional outcomes (P value 0.04), with some concern of safety as the results tended to be better in the control groups; however, owing to the small sample size, no definite conclusions could be reached. The recent RCTs in this area have been conducted [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>–<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. Their results are variable. Xiong 2024 reported a significantly better performance of TNK than the best medical management and excellent and favorable functional outcomes, with a better safety profile, with no statistical significance [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. However, Coutts 2024 reported that the best medical management was better than the TNK group in terms of safety and efficacy profiles, with fewer adverse effects in the best medical management group [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. This may be because Coutts 2024 included patients with minor ischemic stroke. Further RCTs are needed to further evaluate TNK usage in this field.</p></section><section id="Sec15"><h2 class="pmc_sec_title">Strengths and limitations</h2>
<p id="Par57">The study has several strengths as it is the most up-to-date on this important topic. We included randomized control trials in different ethnicities to strengthen our evidence. Our study found that TNK is superior to alteplase in achieving excellent functional outcomes and is not inferior in terms of safety profile. Therefore, ischemic stroke management guidelines further recommend 0.25 mg/kg TNK as an alternative superior choice to alteplase (tPA). This will make managing acute ischemic stroke more flexible if alteplase is not available.</p>
<p id="Par58">On the other hand, some limitations are present; we include other doses of TNK, which are TNK 0.1 mg/kg and 0.4 mg/kg does. These doses lack sufficient data to interpret their results, so we cannot make a final conclusion about their results unless other randomized controlled trials are conducted. In addition, seven RCTs had some concerns related to quality assessment, limiting the reliability of their results. Another limitation is the wide range of confidence intervals for symptomatic intracranial hemorrhage (sICH) when TNK 0.25 mg/kg is compared with alteplase, which makes it difficult to make a definitive conclusion. Finally, a previous systematic review has been published in this scope with similar results.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par59">We present the most up-to-date study to compare different doses of TNK versus alteplase in patients with acute ischemic stroke and demonstrate that 0.25 mg/kg TNK provides the best overall outcomes. Compared with alteplase, 0.25 mg/kg TNK is superior in terms of excellent functional outcomes and is not inferior in terms of major neurological improvements and safety outcomes. This conclusion is based on the significance of the outcome P values and their corresponding confidence interval. The current knowledge supports that 0.25 mg/kg TNK is the best dose option in achieving efficacy and safety for the treatment of acute ischemic stroke to date. The available data suggest that TNK 0.1 and 0.4 doses are not good options; however, several RCTs are needed to confirm this. Currently, 0.25 mg/kg TNK can be administered safely for patients with acute ischemic stroke within 4.5 h of onset, with better outcomes than alteplase.</p></section><section id="Sec18"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12333306/bin/40001_2025_2983_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1</a><sup> (537.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12333306/bin/40001_2025_2983_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 2</a><sup> (475.5KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>No acknowledgment with this study</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>TNK</dt>
<dd><p id="Par6">Tenecteplase</p></dd>
<dt>tPA</dt>
<dd><p id="Par7">Alteplase</p></dd>
<dt>AIS</dt>
<dd><p id="Par8">Acute ischemic stroke</p></dd>
<dt>NIHSS</dt>
<dd><p id="Par9">National institutes of health stroke scale</p></dd>
<dt>mRS</dt>
<dd><p id="Par10">Modified Rankin score</p></dd>
<dt>sICH</dt>
<dd><p id="Par11">Systemic intracranial hemorrhage</p></dd>
<dt>ECASS</dt>
<dd><p id="Par12">European cooperative acute stroke study</p></dd>
<dt>ESO</dt>
<dd><p id="Par13">European stroke organization</p></dd>
<dt>STEMI</dt>
<dd><p id="Par14">ST-segment elevation myocardial infarction</p></dd>
<dt>PCI</dt>
<dd><p id="Par15">Percutaneous coronary intervention</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Abdelmonam M Hagag: is the first author of this article, had the research idea, do the literature review, conducted the meta-analysis, performed the manuscript draft, and participated in the writing Muhammed E. Kormod participated in data extraction and meta-analysis Mahmoud Elmwafy Ads: participated in Full-text screening and data extraction Mennatullah A. El-Refaay: participated in full-text screening, data extraction, and quality assessment Omnia M. Abozaid: Full-text screening and data extraction Omar A. Ghanem Participated in the title and abstract screening and full-text screening Mazen Yasser: Participated in the title and abstract screening Karim M. Abdelmoaty Participated in the full-text screening Alaa Mahmoud Khedr Participated in Writing the manuscript Gregory W Albers was the supervisor of the study, revised the included studies, data extraction sheets and revised the manuscript.</p>
<section id="d33e2573"><h3 class="pmc_sec_title">Authorship</h3>
<p id="Par60">All authors have met the authorship requirement.</p></section></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par61">Not required.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par62">All authors have agreed to publish this study.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par63">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>GBD 2019 Stroke Collaborators. Stroke Collaborators. 2021 Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2019;20:795–820.</cite> [<a href="https://doi.org/10.1016/S1474-4422(21)00252-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8443449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34487721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?GBD%202019%20Stroke%20Collaborators.%20Stroke%20Collaborators.%202021%20Global,%20regional,%20and%20national%20burden%20of%20stroke%20and%20its%20risk%20factors,%201990%E2%80%932019:%20a%20systematic%20analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202019.%20Lancet%20Neurol.%202019;20:795%E2%80%93820." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association. Circulation. 2018;137.</cite> [<a href="https://doi.org/10.1161/CIR.0000000000000558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29386200/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;2018:49.</cite> [<a href="https://doi.org/10.1161/STR.0000000000000158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29367334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Powers%20WJ,%20Rabinstein%20AA,%20Ackerson%20T,%20Adeoye%20OM,%20Bambakidis%20NC,%20Becker%20K,%20et%20al.%20Guidelines%20for%20the%20early%20management%20of%20patients%20with%20acute%20ischemic%20stroke:%20a%20guideline%20for%20healthcare%20professionals%20from%20the%20American%20heart%20association/American%20stroke%20association.%20Stroke.%202018;2018:49." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Jadhav AP, Desai SM, Jovin TG. Indications for mechanical thrombectomy for acute ischemic stroke: current guidelines and beyond. Neurology. 2021;97:S126–36.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000012801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34785611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jadhav%20AP,%20Desai%20SM,%20Jovin%20TG.%20Indications%20for%20mechanical%20thrombectomy%20for%20acute%20ischemic%20stroke:%20current%20guidelines%20and%20beyond.%20Neurology.%202021;97:S126%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Group TNI of ND and S rt-PSS. Tissue plasminogen activator for acute ischemic stroke. New England J Med. 1995;333:1581–8. 10.1056/NEJM199512143332401.
</cite> [<a href="https://doi.org/10.1056/NEJM199512143332401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7477192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Group%20TNI%20of%20ND%20and%20S%20rt-PSS.%20Tissue%20plasminogen%20activator%20for%20acute%20ischemic%20stroke.%20New%20England%20J%20Med.%201995;333:1581%E2%80%938.%2010.1056/NEJM199512143332401." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA. 1995;274:1017–25.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7563451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hacke%20W,%20Kaste%20M,%20Fieschi%20C,%20Toni%20D,%20Lesaffre%20E,%20Von%20Kummer%20R,%20et%20al.%20Intravenous%20thrombolysis%20with%20recombinant%20tissue%20plasminogen%20activator%20for%20acute%20hemispheric%20stroke:%20the%20European%20cooperative%20acute%20stroke%20study%20(ECASS).%20JAMA.%201995;274:1017%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Tanswell P, Modi N, Combs D, Danays T. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet. 2002;41:1229–45.
</cite> [<a href="https://doi.org/10.2165/00003088-200241150-00001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12452736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tanswell%20P,%20Modi%20N,%20Combs%20D,%20Danays%20T.%20Pharmacokinetics%20and%20pharmacodynamics%20of%20tenecteplase%20in%20fibrinolytic%20therapy%20of%20acute%20myocardial%20infarction.%20Clin%20Pharmacokinet.%202002;41:1229%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang L, Hao M, Wu N, Wu S, Fisher M, Xiong Y. Comprehensive review of tenecteplase for thrombolysis in acute ischemic stroke. J Am Heart Assoc. 2024;13: e031692.
</cite> [<a href="https://doi.org/10.1161/JAHA.123.031692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11179942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38686848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20L,%20Hao%20M,%20Wu%20N,%20Wu%20S,%20Fisher%20M,%20Xiong%20Y.%20Comprehensive%20review%20of%20tenecteplase%20for%20thrombolysis%20in%20acute%20ischemic%20stroke.%20J%20Am%20Heart%20Assoc.%202024;13:%20e031692." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Van De Werf FJ. The ideal fibrinolytic: can drug design improve clinical results? Eur Heart J. 1999;20:1452–8.
</cite> [<a href="https://doi.org/10.1053/euhj.1999.1659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10493843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20De%20Werf%20FJ.%20The%20ideal%20fibrinolytic:%20can%20drug%20design%20improve%20clinical%20results?%20Eur%20Heart%20J.%201999;20:1452%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Logallo N, Kvistad CE, Nacu A, Thomassen L. Novel thrombolytics for acute ischemic stroke: challenges and opportunities. CNS Drugs. 2016;30:101–8. 10.1007/s40263-015-0307-2.
</cite> [<a href="https://doi.org/10.1007/s40263-015-0307-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26798040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Logallo%20N,%20Kvistad%20CE,%20Nacu%20A,%20Thomassen%20L.%20Novel%20thrombolytics%20for%20acute%20ischemic%20stroke:%20challenges%20and%20opportunities.%20CNS%20Drugs.%202016;30:101%E2%80%938.%2010.1007/s40263-015-0307-2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Keyt BA, Paoni NF, Refino CJ, Berleau L, Nguyen H, Chow A, et al. A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A. 1994;91:3670–4.
</cite> [<a href="https://doi.org/10.1073/pnas.91.9.3670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC43643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8170967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keyt%20BA,%20Paoni%20NF,%20Refino%20CJ,%20Berleau%20L,%20Nguyen%20H,%20Chow%20A,%20et%20al.%20A%20faster-acting%20and%20more%20potent%20form%20of%20tissue%20plasminogen%20activator.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201994;91:3670%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Van de Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 1999;354:716–22.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(99)07403-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10475182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20de%20Werf%20F,%20Adgey%20J,%20Ardissino%20D,%20Armstrong%20PW,%20Aylward%20P,%20Barbash%20G,%20et%20al.%20Single-bolus%20tenecteplase%20compared%20with%20front-loaded%20alteplase%20in%20acute%20myocardial%20infarction:%20the%20ASSENT-2%20double-blind%20randomised%20trial.%20Lancet.%201999;354:716%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Rønning OM, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 2017;16:781–8.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(17)30253-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28780236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Logallo%20N,%20Novotny%20V,%20Assmus%20J,%20Kvistad%20CE,%20Alteheld%20L,%20R%C3%B8nning%20OM,%20et%20al.%20Tenecteplase%20versus%20alteplase%20for%20management%20of%20acute%20ischaemic%20stroke%20(NOR-TEST):%20a%20phase%203,%20randomised,%20open-label,%20blinded%20endpoint%20trial.%20Lancet%20Neurol.%202017;16:781%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Bivard A, Zhao H, Churilov L, Campbell BCV, Coote S, Yassi N, et al. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial. Lancet Neurol. 2022;21:520–7.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(22)00171-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35525251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bivard%20A,%20Zhao%20H,%20Churilov%20L,%20Campbell%20BCV,%20Coote%20S,%20Yassi%20N,%20et%20al.%20Comparison%20of%20tenecteplase%20with%20alteplase%20for%20the%20early%20treatment%20of%20ischaemic%20stroke%20in%20the%20Melbourne%20Mobile%20Stroke%20Unit%20(TASTE-A):%20a%20phase%202,%20randomised,%20open-label%20trial.%20Lancet%20Neurol.%202022;21:520%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378:1573–82.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1716405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29694815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campbell%20BCV,%20Mitchell%20PJ,%20Churilov%20L,%20Yassi%20N,%20Kleinig%20TJ,%20Dowling%20RJ,%20et%20al.%20Tenecteplase%20versus%20Alteplase%20before%20Thrombectomy%20for%20Ischemic%20Stroke.%20N%20Engl%20J%20Med.%202018;378:1573%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Haley EC, Thompson JLP, Grotta JC, Lyden PD, Hemmen TG, Brown DL, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke. 2010;41:707–11.
</cite> [<a href="https://doi.org/10.1161/STROKEAHA.109.572040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2860601/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20185783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haley%20EC,%20Thompson%20JLP,%20Grotta%20JC,%20Lyden%20PD,%20Hemmen%20TG,%20Brown%20DL,%20et%20al.%20Phase%20IIB/III%20trial%20of%20tenecteplase%20in%20acute%20ischemic%20stroke:%20results%20of%20a%20prematurely%20terminated%20randomized%20clinical%20trial.%20Stroke.%202010;41:707%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Mahawish K, Gommans J, Kleinig T, Lallu B, Tyson A, Ranta A. Switching to tenecteplase for stroke thrombolysis. Stroke. 2021;52:10.</cite> [<a href="https://doi.org/10.1161/STROKEAHA.121.035931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34465202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahawish%20K,%20Gommans%20J,%20Kleinig%20T,%20Lallu%20B,%20Tyson%20A,%20Ranta%20A.%20Switching%20to%20tenecteplase%20for%20stroke%20thrombolysis.%20Stroke.%202021;52:10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Alamowitch S, Turc G, Palaiodimou L, Bivard A, Cameron A, De Marchis GM, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J. 2023;8:8–54.
</cite> [<a href="https://doi.org/10.1177/23969873221150022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10069183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37021186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alamowitch%20S,%20Turc%20G,%20Palaiodimou%20L,%20Bivard%20A,%20Cameron%20A,%20De%20Marchis%20GM,%20et%20al.%20European%20Stroke%20Organisation%20(ESO)%20expedited%20recommendation%20on%20tenecteplase%20for%20acute%20ischaemic%20stroke.%20Eur%20Stroke%20J.%202023;8:8%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Berge E, Whiteley W, Audebert H, De MGM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6:1–56.</cite> [<a href="https://doi.org/10.1177/2396987321989865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7995316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33817340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berge%20E,%20Whiteley%20W,%20Audebert%20H,%20De%20MGM,%20Fonseca%20AC,%20Padiglioni%20C,%20et%20al.%20European%20Stroke%20Organisation%20(ESO)%20guidelines%20on%20intravenous%20thrombolysis%20for%20acute%20ischaemic%20stroke.%20Eur%20Stroke%20J.%202021;6:1%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Muir KW, Ford GA, Ford I, Wardlaw JM, McConnachie A, Greenlaw N, et al. Tenecteplase versus alteplase for acute stroke within 4.5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial. Lancet Neurol. 2024;23:1087–96.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(24)00377-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39424558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muir%20KW,%20Ford%20GA,%20Ford%20I,%20Wardlaw%20JM,%20McConnachie%20A,%20Greenlaw%20N,%20et%20al.%20Tenecteplase%20versus%20alteplase%20for%20acute%20stroke%20within%204.5%20h%20of%20onset%20(ATTEST-2):%20a%20randomised,%20parallel%20group,%20open-label%20trial.%20Lancet%20Neurol.%202024;23:1087%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Meng X, Li S, Dai H, Lu G, Wang W, Che F, et al. Tenecteplase vs alteplase for patients with acute ischemic stroke: the ORIGINAL randomized clinical trial. JAMA. 2024;332:1437–45.
</cite> [<a href="https://doi.org/10.1001/jama.2024.14721" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11393753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39264623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meng%20X,%20Li%20S,%20Dai%20H,%20Lu%20G,%20Wang%20W,%20Che%20F,%20et%20al.%20Tenecteplase%20vs%20alteplase%20for%20patients%20with%20acute%20ischemic%20stroke:%20the%20ORIGINAL%20randomized%20clinical%20trial.%20JAMA.%202024;332:1437%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Parsons MW, Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell BCV, Russell ML, et al. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial. Lancet Neurol. 2024;23:775–86.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(24)00206-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38880118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parsons%20MW,%20Yogendrakumar%20V,%20Churilov%20L,%20Garcia-Esperon%20C,%20Campbell%20BCV,%20Russell%20ML,%20et%20al.%20Tenecteplase%20versus%20alteplase%20for%20thrombolysis%20in%20patients%20selected%20by%20use%20of%20perfusion%20imaging%20within%204%C2%B75%20h%20of%20onset%20of%20ischaemic%20stroke%20(TASTE):%20a%20multicentre,%20randomised,%20controlled,%20phase%203%20non-inferiority%20trial.%20Lancet%20Neurol.%202024;23:775%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Page MJ, Mckenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. 10.1136/bmj.n71.
</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Page%20MJ,%20Mckenzie%20JE,%20Bossuyt%20PM,%20Boutron%20I,%20Hoffmann%20TC,%20Mulrow%20CD,%20et%20al.%20The%20PRISMA%202020%20statement:%20an%20updated%20guideline%20for%20reporting%20systematic%20reviews.%20BMJ.%202021.%2010.1136/bmj.n71." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. New England J Med. 2008;359:1317–29. 10.1056/NEJMoa0804656.
</cite> [<a href="https://doi.org/10.1056/NEJMoa0804656" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18815396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hacke%20W,%20Kaste%20M,%20Bluhmki%20E,%20Brozman%20M,%20D%C3%A1valos%20A,%20Guidetti%20D,%20et%20al.%20Thrombolysis%20with%20Alteplase%203%20to%204.5%20Hours%20after%20Acute%20Ischemic%20Stroke.%20New%20England%20J%20Med.%202008;359:1317%E2%80%9329.%2010.1056/NEJMoa0804656." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28:366.</cite> [<a href="https://doi.org/10.1136/bmj.l4898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sterne%20JAC,%20Savovi%C4%87%20J,%20Page%20MJ,%20Elbers%20RG,%20Blencowe%20NS,%20Boutron%20I,%20et%20al.%20RoB%202:%20a%20revised%20tool%20for%20assessing%20risk%20of%20bias%20in%20randomised%20trials.%20BMJ.%202019;28:366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45:139–45.
</cite> [<a href="https://doi.org/10.1016/j.cct.2015.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4639420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26343745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?DerSimonian%20R,%20Laird%20N.%20Meta-analysis%20in%20clinical%20trials%20revisited.%20Contemp%20Clin%20Trials.%202015;45:139%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Wang Y, Li S, Pan Y, Li H, Parsons MW, Campbell BCV, et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial. Lancet. 2023;401:645–54.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(22)02600-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36774935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Li%20S,%20Pan%20Y,%20Li%20H,%20Parsons%20MW,%20Campbell%20BCV,%20et%20al.%20Tenecteplase%20versus%20alteplase%20in%20acute%20ischaemic%20cerebrovascular%20events%20(TRACE-2):%20a%20phase%203,%20multicentre,%20open-label,%20randomised%20controlled,%20non-inferiority%20trial.%20Lancet.%202023;401:645%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A Randomized trial of tenecteplase versus alteplase for acute ischemic stroke. New England J Med. 2012;366:1099–107. 10.1056/NEJMoa1109842.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1109842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22435369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parsons%20M,%20Spratt%20N,%20Bivard%20A,%20Campbell%20B,%20Chung%20K,%20Miteff%20F,%20et%20al.%20A%20Randomized%20trial%20of%20tenecteplase%20versus%20alteplase%20for%20acute%20ischemic%20stroke.%20New%20England%20J%20Med.%202012;366:1099%E2%80%93107.%2010.1056/NEJMoa1109842." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400:161–9.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(22)01054-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35779553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Menon%20BK,%20Buck%20BH,%20Singh%20N,%20Deschaintre%20Y,%20Almekhlafi%20MA,%20Coutts%20SB,%20et%20al.%20Intravenous%20tenecteplase%20compared%20with%20alteplase%20for%20acute%20ischaemic%20stroke%20in%20Canada%20(AcT):%20a%20pragmatic,%20multicentre,%20open-label,%20registry-linked,%20randomised,%20controlled,%20non-inferiority%20trial.%20Lancet.%202022;400:161%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Li S, Pan Y, Wang Z, Liang Z, Chen H, Wang D, et al. Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study. Stroke Vasc Neurol. 2022;7:47–53.
</cite> [<a href="https://doi.org/10.1136/svn-2021-000978" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8899644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34429364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20S,%20Pan%20Y,%20Wang%20Z,%20Liang%20Z,%20Chen%20H,%20Wang%20D,%20et%20al.%20Safety%20and%20efficacy%20of%20tenecteplase%20versus%20alteplase%20in%20patients%20with%20acute%20ischaemic%20stroke%20(TRACE):%20a%20multicentre,%20randomised,%20open%20label,%20blinded-endpoint%20(PROBE)%20controlled%20phase%20II%20study.%20Stroke%20Vasc%20Neurol.%202022;7:47%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Kvistad CE, Næss H, Helleberg BH, Idicula T, Hagberg G, Nordby LM, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022;21:511–9.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(22)00124-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35525250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kvistad%20CE,%20N%C3%A6ss%20H,%20Helleberg%20BH,%20Idicula%20T,%20Hagberg%20G,%20Nordby%20LM,%20et%20al.%20Tenecteplase%20versus%20alteplase%20for%20the%20management%20of%20acute%20ischaemic%20stroke%20in%20Norway%20(NOR-TEST%202,%20part%20A):%20a%20phase%203,%20randomised,%20open-label,%20blinded%20endpoint,%20non-inferiority%20trial.%20Lancet%20Neurol.%202022;21:511%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 2015;14:368–76.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(15)70017-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25726502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Cheripelli%20BK,%20Lloyd%20SM,%20Kalladka%20D,%20Moreton%20FC,%20Siddiqui%20A,%20et%20al.%20Alteplase%20versus%20tenecteplase%20for%20thrombolysis%20after%20ischaemic%20stroke%20(ATTEST):%20a%20phase%202,%20randomised,%20open-label,%20blinded%20endpoint%20study.%20Lancet%20Neurol.%202015;14:368%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Wu N, Doeppner TR, Hermann DM, Gronewold J. Efficacy and safety of intravenous tenecteplase compared to alteplase before mechanical thrombectomy in acute ischemic stroke: a meta-analysis. J Neurol. 2024;271:3928–41. 10.1007/s00415-024-12445-7.
</cite> [<a href="https://doi.org/10.1007/s00415-024-12445-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11233346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38782799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20N,%20Doeppner%20TR,%20Hermann%20DM,%20Gronewold%20J.%20Efficacy%20and%20safety%20of%20intravenous%20tenecteplase%20compared%20to%20alteplase%20before%20mechanical%20thrombectomy%20in%20acute%20ischemic%20stroke:%20a%20meta-analysis.%20J%20Neurol.%202024;271:3928%E2%80%9341.%2010.1007/s00415-024-12445-7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Koh JH, Lim CYJ, Tan LTP, Sia CH, Poh KK, Sharma VK, et al. Ethnic differences in the safety and efficacy of Tenecteplase versus Alteplase for acute ischemic stroke: a systematic review and meta-analysis. J Stroke. 2024. 10.5853/jos.2024.01284.
</cite> [<a href="https://doi.org/10.5853/jos.2024.01284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11471352/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39266015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koh%20JH,%20Lim%20CYJ,%20Tan%20LTP,%20Sia%20CH,%20Poh%20KK,%20Sharma%20VK,%20et%20al.%20Ethnic%20differences%20in%20the%20safety%20and%20efficacy%20of%20Tenecteplase%20versus%20Alteplase%20for%20acute%20ischemic%20stroke:%20a%20systematic%20review%20and%20meta-analysis.%20J%20Stroke.%202024.%2010.5853/jos.2024.01284." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Xiong Y, Wang L, Li G, Yang K-X, Hao M, Li S, et al. Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials. Stroke Vasc Neurol. 2024;9:360–6. 10.1136/svn-2023-002396.
</cite> [<a href="https://doi.org/10.1136/svn-2023-002396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11420912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37640500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiong%20Y,%20Wang%20L,%20Li%20G,%20Yang%20K-X,%20Hao%20M,%20Li%20S,%20et%20al.%20Tenecteplase%20versus%20alteplase%20for%20acute%20ischaemic%20stroke:%20a%20meta-analysis%20of%20phase%20III%20randomised%20trials.%20Stroke%20Vasc%20Neurol.%202024;9:360%E2%80%936.%2010.1136/svn-2023-002396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Palaiodimou L, Katsanos AH, Turc G, Asimakopoulos A-G, Mavridis D, Schellinger PD, et al. Tenecteplase vs Alteplase in acute ischemic stroke within 4.5 Hours: a systematic review and meta-analysis of randomized trials. Neurology. 2024;103: e209903.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000209903" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39413337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Palaiodimou%20L,%20Katsanos%20AH,%20Turc%20G,%20Asimakopoulos%20A-G,%20Mavridis%20D,%20Schellinger%20PD,%20et%20al.%20Tenecteplase%20vs%20Alteplase%20in%20acute%20ischemic%20stroke%20within%204.5%20Hours:%20a%20systematic%20review%20and%20meta-analysis%20of%20randomized%20trials.%20Neurology.%202024;103:%20e209903." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Srisurapanont K, Uawithya E, Dhanasomboon P, Pollasen N, Thiankhaw K. Comparative efficacy and safety among different doses of tenecteplase for acute ischemic stroke: a systematic review and network meta-analysis. J Stroke Cerebrovasc Dis. 2024;33: 107822.
</cite> [<a href="https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38897370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Srisurapanont%20K,%20Uawithya%20E,%20Dhanasomboon%20P,%20Pollasen%20N,%20Thiankhaw%20K.%20Comparative%20efficacy%20and%20safety%20among%20different%20doses%20of%20tenecteplase%20for%20acute%20ischemic%20stroke:%20a%20systematic%20review%20and%20network%20meta-analysis.%20J%20Stroke%20Cerebrovasc%20Dis.%202024;33:%20107822." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Warach SJ, Ranta A, Kim J, Song SS, Wallace A, Beharry J, et al. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke. JAMA Neurol. 2023;80:732.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2023.1449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10230371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37252708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Warach%20SJ,%20Ranta%20A,%20Kim%20J,%20Song%20SS,%20Wallace%20A,%20Beharry%20J,%20et%20al.%20Symptomatic%20Intracranial%20Hemorrhage%20With%20Tenecteplase%20vs%20Alteplase%20in%20Patients%20With%20Acute%20Ischemic%20Stroke.%20JAMA%20Neurol.%202023;80:732." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Liu Y, Lu G, Li D, Wu G, Zhou X, Qu R, et al. Tenecteplase thrombolytic therapy for acute ischaemic stroke in China: a real-world, multicentre, retrospective, controlled study. Stroke Vasc Neurol. 2024. 10.1136/svn-2024-003381.
</cite> [<a href="https://doi.org/10.1136/svn-2024-003381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39537238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Lu%20G,%20Li%20D,%20Wu%20G,%20Zhou%20X,%20Qu%20R,%20et%20al.%20Tenecteplase%20thrombolytic%20therapy%20for%20acute%20ischaemic%20stroke%20in%20China:%20a%20real-world,%20multicentre,%20retrospective,%20controlled%20study.%20Stroke%20Vasc%20Neurol.%202024.%2010.1136/svn-2024-003381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Skärlund M, Åsberg S, Eriksson M, Lundström E. Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study. Ups J Med Sci. 2024;129: e10459.</cite> [<a href="https://doi.org/10.48101/ujms.v129.10459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11549729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39525073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sk%C3%A4rlund%20M,%20%C3%85sberg%20S,%20Eriksson%20M,%20Lundstr%C3%B6m%20E.%20Tenecteplase%20compared%20to%20alteplase%20in%20real-world%20outcome:%20A%20Swedish%20Stroke%20Register%20study.%20Ups%20J%20Med%20Sci.%202024;129:%20e10459." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Qiu Z, Li F, Xie D, Yuan G, Nguyen TN, Zhou K, et al. Efficacy and safety of intravenous tenecteplase before endovascular thrombectomy for acute ischemic stroke: the multicenter, randomized, BRIDGE-TNK trial protocol. J Am Heart Assoc. 2024;13(21): e036765.
</cite> [<a href="https://doi.org/10.1161/JAHA.124.036765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11935713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39435713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20Z,%20Li%20F,%20Xie%20D,%20Yuan%20G,%20Nguyen%20TN,%20Zhou%20K,%20et%20al.%20Efficacy%20and%20safety%20of%20intravenous%20tenecteplase%20before%20endovascular%20thrombectomy%20for%20acute%20ischemic%20stroke:%20the%20multicenter,%20randomized,%20BRIDGE-TNK%20trial%20protocol.%20J%20Am%20Heart%20Assoc.%202024;13(21):%20e036765." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Liu L, Li W, Qiu J, Nguyen TN, Wei M, Wang F, et al. Improving neurological outcome for acute basilar artery occlusion with sufficient recanalization after thrombectomy by intraarterial tenecteplase (INSIST-IT): Rationale and design. Eur Stroke J. 2023;8:591–7.
</cite> [<a href="https://doi.org/10.1177/23969873231164790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10334187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37231688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20L,%20Li%20W,%20Qiu%20J,%20Nguyen%20TN,%20Wei%20M,%20Wang%20F,%20et%20al.%20Improving%20neurological%20outcome%20for%20acute%20basilar%20artery%20occlusion%20with%20sufficient%20recanalization%20after%20thrombectomy%20by%20intraarterial%20tenecteplase%20(INSIST-IT):%20Rationale%20and%20design.%20Eur%20Stroke%20J.%202023;8:591%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Hu W, Tao C, Wang L, Chen Z, Li D, Chen W, et al. Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial. BMJ. 2025;388: e080489.
</cite> [<a href="https://doi.org/10.1136/bmj-2024-080489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11729139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39809509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20W,%20Tao%20C,%20Wang%20L,%20Chen%20Z,%20Li%20D,%20Chen%20W,%20et%20al.%20Intra-arterial%20tenecteplase%20after%20successful%20endovascular%20recanalisation%20in%20patients%20with%20acute%20posterior%20circulation%20arterial%20occlusion%20(ATTENTION-IA):%20multicentre%20randomised%20controlled%20trial.%20BMJ.%202025;388:%20e080489." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Huang J, Yang J, Liu C, Li L, Yang D, Guo C, et al. Intra-arterial tenecteplase following endovascular reperfusion for large vessel occlusion acute ischemic stroke: the POST-TNK randomized clinical trial. JAMA. 2025;333(7):579–88.
</cite> [<a href="https://doi.org/10.1001/jama.2024.23466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11836761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39804681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20J,%20Yang%20J,%20Liu%20C,%20Li%20L,%20Yang%20D,%20Guo%20C,%20et%20al.%20Intra-arterial%20tenecteplase%20following%20endovascular%20reperfusion%20for%20large%20vessel%20occlusion%20acute%20ischemic%20stroke:%20the%20POST-TNK%20randomized%20clinical%20trial.%20JAMA.%202025;333(7):579%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Xiong Y, Campbell BCV, Schwamm LH, Meng X, Jin A, Parsons MW, et al. Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy. New England J Med. 2024;391:203–12. 10.1056/NEJMoa2402980.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2402980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38884324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiong%20Y,%20Campbell%20BCV,%20Schwamm%20LH,%20Meng%20X,%20Jin%20A,%20Parsons%20MW,%20et%20al.%20Tenecteplase%20for%20Ischemic%20Stroke%20at%204.5%20to%2024%20Hours%20without%20Thrombectomy.%20New%20England%20J%20Med.%202024;391:203%E2%80%9312.%2010.1056/NEJMoa2402980." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Cheng X, Hong L, Churilov L, Lin L, Ling Y, Zhang J, et al. Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial. Stroke Vasc Neurol. 2024;9:551–9. 10.1136/svn-2023-002820.
</cite> [<a href="https://doi.org/10.1136/svn-2023-002820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11732838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38286484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20X,%20Hong%20L,%20Churilov%20L,%20Lin%20L,%20Ling%20Y,%20Zhang%20J,%20et%20al.%20Tenecteplase%20thrombolysis%20for%20stroke%20up%20to%2024%20hours%20after%20onset%20with%20perfusion%20imaging%20selection:%20the%20umbrella%20phase%20IIa%20CHABLIS-T%20randomised%20clinical%20trial.%20Stroke%20Vasc%20Neurol.%202024;9:551%E2%80%939.%2010.1136/svn-2023-002820." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, et al. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial. Lancet. 2024;403:2597–605.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(24)00921-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38768626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coutts%20SB,%20Ankolekar%20S,%20Appireddy%20R,%20Arenillas%20JF,%20Assis%20Z,%20Bailey%20P,%20et%20al.%20Tenecteplase%20versus%20standard%20of%20care%20for%20minor%20ischaemic%20stroke%20with%20proven%20occlusion%20(TEMPO-2):%20a%20randomised,%20open%20label,%20phase%203%20superiority%20trial.%20Lancet.%202024;403:2597%E2%80%93605." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, et al. Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK Part 2 randomized clinical trial. JAMA. 2020;323:1257–65.
</cite> [<a href="https://doi.org/10.1001/jama.2020.1511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7139271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32078683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campbell%20BCV,%20Mitchell%20PJ,%20Churilov%20L,%20Yassi%20N,%20Kleinig%20TJ,%20Dowling%20RJ,%20et%20al.%20Effect%20of%20intravenous%20tenecteplase%20dose%20on%20cerebral%20reperfusion%20before%20thrombectomy%20in%20patients%20with%20large%20vessel%20occlusion%20ischemic%20stroke:%20the%20EXTEND-IA%20TNK%20Part%202%20randomized%20clinical%20trial.%20JAMA.%202020;323:1257%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12333306/bin/40001_2025_2983_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1</a><sup> (537.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12333306/bin/40001_2025_2983_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 2</a><sup> (475.5KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from European Journal of Medical Research are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40001-025-02983-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40001_2025_Article_2983.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12333306/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12333306/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333306%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333306/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12333306/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12333306/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40775658/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12333306/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40775658/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12333306/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12333306/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="fT1m683zdRVbskVuGMWg06qdNyCBbFejfwywcqpVimTaN3aEVs6N0OXh6AUOM8pv">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
